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ABSTRACT 
Bone Mineral Density, Body Composition and Dietary Intake in Asian 
Indian and Caucasian Males 
 
Abeer Ali Aljahdali 
 
 
 
 
Background: The difference in osteoporotic fractures across different ethnic 
groups could be due to the differences in body composition and eating habits. The 
variation in areal bone mineral density (aBMD), body composition and dietary intake 
between immigrant Asian Indians and Caucasians are unknown.  
Objective: The objective of this study was to examine the differences in aBMD, 
body composition and dietary intake between immigrant Asian Indians and Caucasians 
matched for age and body mass index (BMI). Also, we examined the relationship 
between body composition and aBMD and how might the relationships differ between the 
two groups.     
Design: A convenient sample of 32 healthy males who self-identified themselves 
as either Asian Indians (n=16) or Caucasians (n=16) were recruited for this cross-
sectional study. Dual-energy x-ray absorptiometry (DXA) was used for measuring aBMD 
and bone mineral content (BMC) at the lumbar spine, femoral neck, 33% radius of the 
non-dominant hand and whole body. Body composition was measured using whole body 
scan by DXA. Dietary intake was assessed using 24-hour food recall and food frequency 
questionnaires.    
xii 
 
 
 
Results: There was no difference between groups in age and BMI. Lean mass was 
lower in Asian Indians compared Caucasians (p=0.03). aBMD at measured sites were 
similar between two groups (all p˃0.05). However, BMC was lower at all skeletal sites 
(all p<0.05). In all overall sample, lean mass correlated positively with aBMD at the 
lumbar spine (p<0.05), but with aBMD at the femoral neck in Caucasian males only 
(p=0.03). Fat mass did not correlate with aBMD at any sites (all p˃0.05). There were no 
differences in the correlation between body composition with aBMD between Asian 
Indians and Caucasians. Regarding dietary intake, calcium and magnesium intakes were 
not different between the two ethnic groups (all p<0.05). 
Conclusion:  Asian Indian men have lower lean mass and BMC at different 
skeletal sites, but similar other body composition variables and dietary intakes compared 
to age and BMI matched Caucasians. Lean mass showed a positive correlation with 
aBMD. Since the scope of this study was limited to examine the difference in bone 
density using aBMD, the study highlights the need for further research to examine the 
variability in bone turnover between immigrant Asian Indians and Caucasians to see if 
the findings from biochemical properties and bone density are similar.   
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CHAPTER 1: INTRODUCTION 
1.1 Introduction  
 Osteoporosis is a public health concern in the United States and around the globe. 
The burden of osteoporotic fracture entails financial, physical, and psychosocial aspects. 
Annually, approximately $10 to $15 billion is the financial cost that is directed to 
hospitals’ care for subjects with osteoporotic fractures in the United States 1. With 
increasing in life expectancy, the proportion of the elderly population is expected to 
increase. Aging is a risk factor for osteoporosis and hence osteoporotic fractures. During 
the last three decades, there has been an increase in hip fractures by 2 to 3 times in Asian 
countries. It has been estimated that more than half of the osteoporotic fractures will 
occur in Asian countries by 2050 2.  
Even though the prevalence of osteoporosis in men is lower than women, the 
expected increase in the men with osteoporosis is 89% compared to 69% in women by 
2025 3. The mortality rate in men is higher due to osteoporosis and osteoporotic fractures 
compared to women in developed and developing countries such as India. In fact, Asian 
Indians have a lower areal bone mineral density (aBMD) compared to Caucasians 
4, 5,6.  
 Body composition differs between subjects from different ethnic groups.  Asian 
Indians have higher body fat, visceral adipose tissue and subcutaneous adipose tissue but 
lower muscle mass compared to Caucasians. Due to the differences in body composition, 
Asian Indians have high prevalence of metabolic syndrome (MetS) and type 2 diabetes at 
young age and normal weight. Therefore, World Health Organization and International 
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Diabetes Federation have established specific cut-off values for BMI and waist 
circumference, respectively for Asians. Moreover, body composition has influences on 
aBMD. Lean mass, for instance, has been shown to have a positive effect on bone. Higher 
body fat, visceral adipose tissue and subcutaneous adipose tissue might impact aBMD 
negatively.   
This thesis will focus on investigating the differences in aBMD, body composition, 
and calcium and magnesium intake between healthy Asian Indian and age and body mass 
index-matched Caucasian males. Also, the study will examine the association between 
body composition and aBMD in healthy young adults and within each ethnic group.  
1.2 Aims and Hypotheses 
1.2.1 Specific Aims and Hypotheses 
Aim 1: To determine whether areal bone mineral density (aBMD) at the lumbar spine, 
femoral neck, and 33% radius of the non-dominant hand and whole-body differ between 
Asian Indian and Caucasian men matched for age and body mass index (BMI)  
• Hypothesis 1.A: Asian Indians will have lower whole-body a BMD compared to 
age, and BMI matched Caucasian men 
• Hypothesis 1.B: Asian Indians will have lower aBMD at the lumbar spine 
compared to age, and BMI matched Caucasian men 
• Hypothesis 1.C: Asian Indians will have lower aBMD at the femoral neck 
compared to age, and BMI matched Caucasian men  
• Hypothesis 1.D: Asian Indians will have lower aBMD at the 33% radius of the 
non-dominant hand compared to age, and BMI matched Caucasian men  
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Aim 2:  To examine whether measured android fat, gynoid fat and lean mass differ 
between Asian Indian and Caucasian men matched for age and BMI 
• Hypothesis 2.A: Android fat will be higher in Asian Indians compared to age, and 
BMI matched Caucasian men 
• Hypothesis 2.B: Gynoid fat will be similar in Asian Indians compared to age, and 
BMI matched Caucasian men  
• Hypothesis 2.C: Lean Mass will be lower in Asian Indians compared to age, and 
BMI matched Caucasian men   
Aim 3:  To determine whether dietary intake of calcium and magnesium differ between 
Asian Indian and Caucasian men matched for age and BMI.   
• Hypothesis 3.A: Asian Indians will have lower intakes of dietary calcium 
compared to age, and BMI matched Caucasian men   
• Hypothesis 3.B: Asian Indians will have similar intakes of dietary magnesium 
compared to age, and BMI matched Caucasian men   
Aim 4:  To determine the relationship between body composition and aBMD at the 
lumbar spine and femoral neck in Asian Indian and Caucasian men matched for age and 
BMI.  
• Hypothesis 4.A: Android fat will be negatively correlated with aBMD at the 
lumbar spine, and femoral neck in Asian Indian and age and BMI matched 
Caucasian men   
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• Hypothesis 4.B: Gynoid fat will be positively correlated with aBMD at the lumbar 
spine, and femoral neck in Asian Indian and age and BMI matched Caucasian 
men   
• Hypothesis 4.C: Lean mass will be positively correlated with aBMD at the lumbar 
spine, and femoral neck in Asian Indian and age and BMI matched Caucasian 
men   
• Hypothesis 4.D: The correlation between android fat, gynoid fat and lean mass 
with aBMD at the lumbar spine and femoral neck will differ for Asian Indian 
compared to age, and BMI matched Caucasian men   
1.2.2 Exploratory Aims and Hypotheses 
Exploratory Aim 1:  To determine whether the percentage of Asian Indians who meet 
the calcium recommended dietary allowance (RDA) by the Indian Council of Medical 
Research will differ from the percentage of Caucasian men who meet the calcium RDA 
by the National Institute of Health  
• Hypothesis: the percentage of Asian Indians who meet the calcium RDA by the 
Indian Council of Medical Research will be lower than the percentage of 
Caucasian men who meet the calcium RDA by the Institute of Medicine 
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Exploratory Aim 2:  To examine whether measured visceral adipose tissue and 
subcutaneous adipose tissue differ between Asian Indian and Caucasian men matched for 
age and BMI. 
• Hypothesis 2.A: Visceral adipose tissue will be higher in Asian Indian compared 
to age, and BMI matched Caucasian men   
• Hypothesis 2.B: Subcutaneous adipose tissue will be higher in Asian Indian 
compared to age, and BMI matched Caucasian men   
Exploratory Aim 3:  To determine whether bone mineral apparent density (BMAD) at 
the lumbar spine, femoral neck, and 33% radius of the non-dominant hand and whole-
body differ between Asian Indian and Caucasian men matched for age and BMI  
• Hypothesis 1.A: Asian Indian men will have similar whole-body BMAD 
compared to age, and BMI matched Caucasian men. 
• Hypothesis 1.B: Asian Indian men will have similar BMAD at the lumbar spine 
compared to age, and BMI matched Caucasian men. 
• Hypothesis 1.C: Asian Indian men will have similar BMAD at the femoral neck 
compared to age, and BMI matched Caucasian men.  
• Hypothesis 1.D: Asian Indian men will have similar BMAD at the 33% radius of 
the non-dominant hand compared to age, and BMI matched Caucasian men.  
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CHAPTER 2: LITERATURE REVIEW 
2.1. Definition of Asian Indian and Caucasian Ethnicity 
Asian Indians are natives of first or subsequent generation immigrants who can 
trace their ancestry to any country of the Indian subcontinent. These countries are India, 
Bangladesh, Nepal, Pakistan and Sri Lanka.  Caucasians are those who trace their 
ancestry to non-Hispanic ethnicity and who do not belong to any other ethnic group.   
2.2. Osteoporosis 
2.2.1 Definition of Osteoporosis 
Osteoporosis is defined by the National Institutes of Health “as a skeletal disorder 
characterized by compromised bone strength predisposing a person to an increased risk of 
fracture.” 1 Osteoporosis has metabolic consequences which go beyond the skeletal 
system; it impacts the body homeostasis 7. Bone strength contains two major components, 
which are bone density and bone quality. Areal bone mineral density (aBMD) is 
expressed as the density of the bone in gram (gm) per centimeter squared (cm2), while 
bone quality composes of various factors about bone structure, bone turnover, “damage 
accumulation (e.g., microfractures) and mineralization.” Multiple assessment tools have 
been developed to measure some aspects of bone quality, but most of them still applied in 
a research setting, not in clinical applications 7. Since bone density accounts for 70% of 
bone strength, bone mineral density is used as a surrogate measure of bone strength 1. 
Therefore, the diagnosis of osteoporosis is based on aBMD measured by Dual Energy X-
ray Absorptiometry (DXA) 8.  
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2.2.2 Diagnosis of Osteoporosis  
According to the World Health Organization (WHO), osteoporosis is diagnosed if 
a subject’s T score is ≥ 2.5 standard deviations (SD) less than the reference aBMD 
measured for healthy young White women between the age 20 to 29 years old 9.  The T-
score is calculated by taking the difference between a subject’s aBMD value at a 
particular site and average aBMD of young adults matched the subject in their sex and 
ethnicity at the same skeletal site and dividing the difference by “young adult population 
SD” as follow, T score=  
Subject′s aBMD −Average young adults aBMD 
Young adult population SD
 10.  
2.2.3 The Common Sites to Measure Areal Bone Mineral Density 
The bone is made of two structural units, which are cortical bone and trabecular 
bone. The cortical bone, or what is called compact bone, is the hard-out layer of the bone. 
It covers the internal part of the bone. On the other hand, trabecular bone is a spongy 
structure which resembles the structure of honeycomb. The distribution of the two bone 
structures varies across the skeletal system. For example, vertebrae, hips, forearm and 
proximal humerus have a higher percentage of trabecular bone than cortical bone. As a 
result, the previously mentioned sites are common sites for osteoporotic fractures, and 
they are commonly used to measure aBMD and assess the risk of osteoporosis 
11.   
2.2.4 Normal Development of the Bone   
As a normal development of bone, the first two decades of an individual’s life is 
where the accumulation of bone mass occurs. During the puberty, the calcium intake is 
used to build the skeleton. Also, calcium is stored in the skeleton to be used in 
maintaining calcium homeostasis during periods of calcium deficiency or insufficiency. 
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In addition to calcium, vitamin D intake and exercise help in achieving optimal peak 
bone mass (PBM) during puberty 12. PBM accounts for approximately 60 % of bone mass 
in adulthood 7. Therefore, PBM is an essential factor in the susceptibility to fractures in 
later life.  From the third decay until the end of the fourth decade, this stage is considered 
as a maintenance stage, where the bone formation equals bone resorption 13. After that, 
the bone loss starts with a rate differs between men and women. The rate is higher in 
women during menopause due to the decline in estrogen level Figure 114.  Ultimately, the 
preventive approach of osteoporosis involves two significant dimensions. The former 
strategy is achieving optimal PBM during childhood and adolescence periods, while the 
latter approach is to slow the rate of the inevitable bone loss which is a standard 
physiological change with aging1.   
9 
 
 
 
 
 
 Figure 1: The Normal Development of Bone Across Lifespan. Adapted from Ishimi, 
2015 14  
 
2.2.5 The Prevalence and Burden of Osteoporosis   
In 2005, the incidence of fractures was more than 2 million in the United States15. 
The prevalence of osteoporosis in developing countries is not well established because of 
the scarcity of the studies conducted on those populations 11. In India, for example, there 
is no an official registry of fractures at the national level, but some hospitals have their 
own fractures registries 16. It was estimated that 26 million of Asian Indians had 
osteoporosis in 2003 and 36 million in 2013 17.  In 2015, 10% of the total deaths 
happened in India was due to fractures according to the cause of death certificate. 18.  
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The burden of osteoporotic fracture entails financial, physical and psychosocial 
aspects. Annually, approximately $10 to $15 billion is the financial cost that is directed to 
hospitals’ care for subjects with osteoporotic fractures in the United States 1. In India, the 
total cost of a hip fracture surgery had been estimated to be 772 US dollars in public 
hospitals with an average hospital stay of 15 days, while the cost was 2360 to 3860 US 
dollar in private hospitals with an average hospital stay of 5 to 6 days 16.  
There is an increase in life expectancy and the elderly population around the 
world. In 1947, the average life expectancy at birth in India was 31 years, while the 
average life expectancy now is 67.14 years19. The percentage of elderly residents in 
Asian countries will be 9.3% in 2025. As a matter of fact, aging increases the risk of 
osteoporosis and fall. During the last three decades, there has been an increase in the hip 
fractures by 2 to 3 times in Asian countries. It has been estimated that there will be more 
than half of the osteoporotic fractures will occur in Asian countries by 2050 2.  
2.2.6 Osteoporosis in Men     
It is a well-established fact that men have higher aBMD than women at any 
skeletal sites and any stage of life. However, the incidence of hip fractures is higher in 
Asian Indian men compared to women counterparts. The incidence of hip fracture was 32 
cases per 100,000 (95% CI 16 – 57) in Asian Indian men compared to 14 cases per 
100,000 (95% CI 4 – 35) in women between the 40 to 44 years of age 20. Even though the 
incidence rates did not statistically differ between sexes, it provides a clue for the high 
susceptibility of hip fractures in Asian Indian men. Moreover, the mortality rate is higher 
in men due to osteoporotic fractures compared women 21. The age-standardized mortality 
11 
 
 
 
ratio (SMRs) were 3.17 vs. 2.18 for the proximal femur, 2.38 vs. 1.66 for the vertebral 
fractures, and 1.45 vs. 0.75 for minor fractures in men and women, respectively21. In 
2015, the total number of deaths due to fractures among Indian men was 5200, while only 
1872 was the number of deaths in Indian women due to fractures 18. 
 Due to the economic prosperity, the life expectancy is now higher in both men 
and women. With an increase in life expectancy, the osteoporosis and osteoporotic 
fractures will be more prevalent in older men because aging is one of the predisposing 
factors in developing fractures. In 2025, the number of hip fractures in men will be 
800,000 cases per a year compared to 424,000 cases in 2000. In women, the number of 
cases was more than one million in 2000, and it will be 1.8 million cases in 2025. Even 
though the number of cases is higher in women than men,  the percentage of increase in 
cases with hip fracture will be 89% in men compared to 69% in women between 2000 to 
2025 3.  Ultimately, it is vital to address the problem of osteoporosis in men like the 
attention has been given to osteoporosis in women.   
2.2.7 Areal Bone Mineral Density in Asian Indians versus Caucasians   
The difference in aBMD between Caucasians and Asian Indians has been 
investigated in several studies, and the findings are intriguing.  Some researchers reported 
that aBMD is lower in Asian Indians compared to Caucasians. The aBMD of 808 healthy 
Asian Indians between the age of 20 to 29 and BMI 18.5 to 25 kg/m2 was measured at the 
lumbar spine (L1-L4), non-dominant forearm, femoral neck and whole body. By 
comparing the Asian Indian’s aBMD with the data collected from the Third National 
Health and Nutrition Examination Survey (NHANES III), Asian Indians have 
12 
 
 
 
significantly lower aBMD at all sites compared to Caucasians (p-value < 0.001)
4. Another 
study conducted to quantify the percentage of difference in aBMD between Asian Indian 
males and Caucasians. Asian Indians had aBMD at the femoral neck, total hip and lumbar 
spine (L1-L4) that were lower than Caucasians’ aBMD by 15.2%, 17.9%, and 16.5%, 
respectively 6.  Makker and colleagues calculated the prevalence of osteoporosis and 
osteopenia in 1004 healthy Asian Indian adults twice using normative aBMD values been 
collected in the study, and data for Caucasians provided by DXA’s manufacture. They 
stated that the use of Caucasians’ aBMD as a reference standard had a “limited validity” 
in Asian Indians 5. On the other hand, a site-specific difference in aBMD was observed in 
healthy and physically active Asian Indian men. Compared to Caucasians, Asian Indians 
had similar aBMD at the femur trochanter, and higher aBMD at femur neck and total 
femur but lower aBMD at the lumbar spine. The authors, however, stated that the 
generalizability of study findings was limited because of the sample studied composed of 
paramilitary personnel who were taller, physically active and consumed more calcium 
and protein than general population 22.  
The difference in skeletal size between Asian Indians and Caucasians has been 
considered as one of the possible causes for lower aBMD in Asian Indians compared to 
Caucasians. Therefore, adjusting for the frame size in comparing aBMD between Asian 
Indians and Caucasians was used before. For that, Roy et al. conducted a study to 
investigate the difference in aBMD and volumetric bone density between Asian Indian 
and European women with and without adjusting for the skeletal size. They found that 
Asian Indians had lower aBMD at the lumbar spine (L1-L4), total hip and the whole body 
13 
 
 
 
compared to European women (p < 0.05). The differences in aBMD at the lumbar spine, 
however, was eliminated by calculating bone mineral apparent density (BMAD) 
(gm/cm3) at the lumbar spine, using the following equation 
𝐴𝑟𝑒𝑎𝑙 𝐵𝑜𝑛𝑒 𝑀𝑖𝑛𝑒𝑟𝑎𝑙 𝐷𝑒𝑛𝑠𝑖𝑡𝑦 𝑎𝑡  𝐿𝑢𝑚𝑏𝑎𝑟 𝑆𝑝𝑖𝑛𝑒(𝑔𝑚/𝑐𝑚2) 
𝐻𝑒𝑖𝑔ℎ𝑡 (𝑚)
 . The BMAD is a way to adjust for the 
skeletal size. The lack of difference in bone density between the two groups was 
supported by the results of  volumetric bone density (mg/cm3) measured by peripheral 
quantitative computed tomography at trabecular and total BMD (mg/cm3) at the distal 
radius  23. Similarly, the differences in aBMD disappeared at femoral neck and total hip 
when aBMD was adjusted for weight and height between: 1) Caucasians and US Asian 
men 24; 2) Caucasians and Asian Indian men 25, 3) Europeans and Asian Indian men 26; 4) 
Europeans and Asians Indian women 27; and 5) Caucasians and Asian Indian women 28. 
Cundy and colleagues stated that Asian Indians has lower aBMD  because of their short 
stature compared to Europeans and Caucasians 27. Asian Indians might have higher bone 
density than Caucasians when the aBMD measurements adjusted for the skeletal size.    
For instance, Mehta et al. found that Asian Indian women had a higher BMAD (gm/cm3) 
at femoral neck compared to Caucasians matched for age 28.  
 DXA calculates aBMD at any site using the following formula 
𝐵𝑜𝑛𝑒 𝑀𝑖𝑛𝑒𝑟𝑎𝑙 𝐶𝑜𝑛𝑡𝑒𝑛𝑡 (𝑔𝑚)
𝑃𝑟𝑜𝑗𝑒𝑐𝑡𝑒𝑑 𝐴𝑟𝑒𝑎 (𝑐𝑚2)
. The denominator in the aBMD equation is only influenced by a 
two-dimensional shape of the bone. In fact, the projected area for whole body aBMD is 
influenced by subject’s height and width. By doing so, bone’ depth or how long the 
DXA’s “beam has to pass” through the bone is ignored. Bone depth is influenced by the 
size of bone. However, the volume or the bone size is not accounted for in aBMD. Carter 
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et al. stated that taller subjects will have higher aBMD compared to shorter subjects 
eventhough they both have simlar volumetric bone denisty 29. Ignoring the impact of 
skeletal size in comparing aBMD between different ethnic groups particularly when they 
differ in their skeletal dimensions is the reason for the variation in aBMD 
27,30,31.    
2.3 Metabolic Syndrome  
2.3.1 Definition of Metabolic Syndrome 
Metabolic syndrome (MetS) is a cluster of proatherogenic hormonal, clinical, and 
anthropometric abnormalities that predispose an individual to develop type 2 diabetes and 
cardiovascular diseases. These risk factors are 1) impaired glucose metabolism or insulin 
insensitivity; 2) obesity or central obesity; 3) high blood pressure (BP); 4) dyslipidemia 
characterized by low high-density lipoprotein cholesterol (HDL-C), high low-density 
lipoprotein cholesterol (LDL-C).  
Although there are multiple diagnostic criteria for MetS developed by many 
organizations, there are two diagnostic criteria are widely used in research, which are the 
National Cholesterol Education Program’s Adult Treatment Panel III report (NCEP/ATP 
III) and the International Diabetes Federation (IDF) criteria.  The NCEP/ATP III was 
established by American Heart Association (AHA) and National Heart Lung and Blood 
Institute. According to NCEP/ATP III, a subject is diagnosed with MetS if s/he has three 
of the following risk factors 1) abdominal obesity (waist circumference for men and 
women > 102, and > 88 cm, respectively); 2) elevated serum Triglycerides [(TG) ≥ 150 
milligrams per deciliter (mg/dL)] ; 3) low serum HDL-C (men < 40 and women <  50 
mg/dl) ; 4) BP ≥  
130 
85
 millimeters of mercury (mmHg); or 5)elevated fasting plasma 
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glucose [(FBG) ≥ 100 mg/dl].  The ethnic difference in the body fat percentage has 
considered in the diagnostic criteria by the IDF. According to IDF criteria, a subject is 
diagnosed with MetS if s/he has central obesity proved either by the waist circumference 
Table 1 or BMI > 30 kg/m2. In addition to central obesity, the subject has to have two of 
the following risk factors: 1) elevated TG ≥ 150 mg/dL or treatment for this lipid 
abnormality; 2) low HDL-C (men < 40 and women <  50 mg/dl) or treatment for this 
lipid abnormality; 3) BP ≥  
130 
85
   (mmHg) or treatment of previously diagnosed 
hypertension; 4) FPG ≥ 100 mg/dL or previously diagnosed type 2 diabetes 32.  
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      TABLE 1 
     Waist Circumference cut-off for Different Ethnic Groups 32  
 
 
 
Country/Ethnic group Waist 
circumference 
Europids 
In the USA, the ATP III values (102 cm male; 88 cm 
female) are likely to continue to be used for clinical 
purposes 
Male ≥ 94 cm 
Female ≥ 80 cm 
South Asians 
Based on a Chinese, Malay and Asian-Indian 
population 
Male ≥ 90 cm 
Female ≥ 80 cm 
Japanese Male ≥ 90 cm 
Female ≥ 80 cm 
Ethnic South and Central Americans 
Use South Asian recommendations until more 
specific data are available 
Male ≥ 90 cm 
Female ≥ 80 cm 
Sub-Saharan Africans 
Use European data until more specific data are 
available 
Male ≥ 94 cm 
Female ≥ 80 cm 
Eastern Mediterranean and Middle East (Arab) 
populations 
Use European data until more specific data are 
available 
Male ≥ 94 cm 
Female ≥ 80 cm 
 
 
 
Adapted from International Diabetes Federation. The IDF consensus worldwide 
definition of the metabolic syndrome, 2006.  
2.3.2   Metabolic Syndrome in Asian Indians  
MetS is very prevalent among Asian Indians in the U.S 33, 34, 35 as well as in India 36. 
The age-adjusted prevalence of MetS in adults age between 19 to 81 living in the U.S 
was 32.7%, and 38.2%, using NCEP/ATP III, and IDF diagnostic criteria, respectively33. 
Flowers and colleagues reported a slightly lower prevalence of MetS (27%) in their 
sample using IDF diagnostic criteria 34. On the other hand, the prevalence of MetS in 
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Caucasian adults between the age 38 to 97 was 23.5% and 18.2% in men and women, 
respectively 37. It has been proved that MetS occurs in Asian Indians at younger ages 
compared to Caucasians38.   
Asians Indians have higher FM and %BF but lower muscle mass compared to 
Caucasians and other Asians. The regional fat distribution is also reported to be higher in 
Asian Indians compared to Caucasians.  Raji et al. observed that healthy Asian Indian 
adults with normal weight had higher total abdominal fat and visceral adipose tissue (all 
p= 0.04) compared to age, sex, and BMI matched Caucasians. Subcutaneous adipose 
tissue  did not differ between the groups 39. On the other hand, Chandalia and colleagues 
found no significant difference in subcutaneous adipose tissue as well as visceral adipose 
tissue between Asian Indian and Caucasian men 40. They investigated the difference in 
the size of adipose cells in subcutaneous adipose tissue. Asian Indians had higher cell 
size on average compared to Caucasians  (p-value = 0.0001) 40. Some researchers have 
linked the size of adipose cells positively with type 2 diabetes and insulin resistance38. 
Misra et al. proposed to lower waist circumference cut-off points for Asian Indians 
further. The suggested cut-off values are 78 cm and 72 cm in Asian Indian men and 
women, respectively to identify abdominal obesity 41.  
Interestingly, environmental and lifestyle factors come to play in predisposing Asian 
Indians to obesity and MetS. Like the nutrition transition seen in western countries, Asian 
Indians are affected by this transition as well due to the economic growth. More 
packaged and processed food are available in supermarkets and food outlets than before. 
Hence the intake of saturated fat, cholesterol, trans fatty acids , refined carbohydrates and 
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calories increases in Asian Indians’ diet38. The daily energy intake in Asian Indian adults 
exceeded their basal metabolic rate33, which might predispose them to weight gain. 
Nonetheless, fruit and vegetable and fiber intakes are low. Shah et al. have measured the 
fiber intake in the diet of young Asian Indian adults. The average fiber intake was 20 ±10 
gm and 18± 8 gm/day in men and women, respectively33, which is lower than the 
recommendation of 38 gm/ day for men and 25 gm/ day for women42. In addition to the 
eating pattern, the physical inactivity is very prevalent among Asian Indians compared 
Caucasians25,38. There has been a consensus to emphasis more on the physical activity 
recommendations to Asian Indians to curb the obesity and MetS. The recommendation is 
to have 60 minutes of physical activity every day including both resistance and aerobic 
exercise 43. All these factors make MetS is very common among Asian Indians.  
2.3.3 Metabolic Syndrome and Osteoporosis  
The relationship between MetS and osteoporosis is attributed to multiple factors. 
Most importantly, osteoporosis and MetS are both caused by genetic, behavioral and 
lifestyle factors and the interaction between these factors. For example, aging is a 
predisposing factor to bone loss and osteoporosis 44. At the same time, aging leads to 
MteS directly or indirectly via an increase in %BF, waist circumference and blood 
pressure, which are predisposing factors to MetS 45. The components of MetS have been 
associated with either increase or decrease the incidence osteoporosis 46,47. Obesity or 
central adiposity, which is the hallmark of MetS, associated with heavier weight and 
higher mechanical load on bone. The bone mass and density increase in response to the 
higher load 44,46,48. It has been estimated the FM only contribute up to 16%43 - 27%44  of 
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body weight in White men. As a result, fat mass is unlikely to explain the positive effect 
alone. However, the FM contributes to a large percentage of body weight in the Asian 
population, which could be the reason for the inconsistency in the findings of the effect of 
FM on aBMD.  Moreover, FM has been recognized recently as an active endocrine organ 
which secretes active metabolites, and hormones involved in the bone metabolism 
whether favorably such as 17-estradiol or negatively such as inflammatory cytokines 44,46. 
Furthermore, osteoblast and adipocyte cells are originated from the same progenitor in 
the bone marrow, which is the mesenchymal stem cell 44,46,48. The differentiation of 
mesenchymal stem to either cell is influenced by some cytokines secreted by 
adipocytes49.  
2.3.3 Previous Findings on the Relationship Between Metabolic Syndrome and 
Osteoporosis 
Muhlen et al. investigated the association between MetS and osteoporosis in 
Caucasian adults. They found that the age-adjusted aBMD at the femoral neck and lumbar 
spine were higher in participants with MetS than participant without MetS (p ≤0.05).  
However, the protective effect of MetS on aBMD reversed by adjusting for BMI in 
addition to age but was not significant at any skeletal site. On the contrary, Yaturu and 
colleagues reported that individuals with MetS had lower aBMD at femoral neck 
compared to the control group (0.892 ± 0.009 vs 0.958± 0.08 gm/cm2, p <0.01)50. Some 
researchers observed a sex-dependent association between MetS and aBMD. Positive 
associations between aBMD at the lumbar spine and total hip in women with MetS but 
not in men45,51. Similarly, the incidence of fracture in subjects with MetS and without 
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MetS differs between men and women. It has observed that women with MetS were 
276% more likely to develop non-vertebral osteoporotic fractures compared women 
without MetS during two years of follow up (Odds Ratios (OR) = 3.76, 95% CI 1.27–
11.13, p = 0.02). The incidence of osteoporotic fractures, however, was not significant for 
men with MetS compared to control (OR = 2.48, 95% CI 0.49 – 12.60, p = 0.27)37. 
The association between osteoporosis and every component of MtS has been 
investigated. For example, the central obesity or waist circumference has been found to 
negatively associated with aBMD at the lumbar spine, femoral neck and total hip (all p < 
0.05) in men with MetS but not in women51. Along the same line, other studies confirmed 
the negative association in young and older Korean adults (p-value < 0.05)45 and 
Dutchmen (p-value  = 0.004)52. 
2.4 Bone Regulating Nutrients 
Lifestyle behaviors influence 20% to 40% of the PBM attainment. One of these 
lifestyle behaviors is nutrition. In fact, nutrition plays a crucial role in the 
bone mineral acquisition, maintenance of bone, and protection against the regular load 
imposed on bone 53. Many nutrients are essential for the bone, but calcium, vitamin D, 
protein and magnesium are the most powerful nutrients.   
2.4.1 Calcium  
Calcium is widely distributed in the body and in average, a subject has one kilogram 
of calcium in his/her body54. About 99% of body calcium is in the skeletal system and 
teeth54, and only 1% is in the extracellular fluid 55. Bone is composed of three 
components: 1) mineral, which accounts for 60%, 2) an organic matrix, which accounts 
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for 30%, and 3) water, which accounts for 10% of total bone. The mineral component 
contains calcium and phosphate, and both compose of what is called Hydroxylapatite (Ca 
10 [PO4]6 [OH]2).  Calcium, also, is a crucial element in contributing to the hardness of 
cortical bone and hence bone strength by increasing the bone mass54,56. Therefore, 
calcium that is stored in the skeleton works as a calcium reservoir to replenish calcium 
during periods of low calcium intake or impaired absorption. In order for stored calcium 
to maintain normal calcium homeostasis, the bone resorption process must start.  
Among one of the modifiable factor for good bone mass during the PBM in 
childhood and adolescence and bone maintenance in adulthood is calcium intake 54. 
Calcium contributes to the bone health through two major ways. The former approach is 
during the PBM since calcium serves as a structural unit in bone tissue. The latter role is 
during the adulthood. Adequate intake of calcium prevents bone resorption and might 
slow the rate of bone loss. On the other hand, low serum calcium concentration triggers 
the release of the Parathyroid hormone (PTH) to initiate the bone resorption process. The 
purpose of bone resorption is to free some calcium from the skeleton to maintain calcium 
homeostasis. In addition to its direct role as a component in the Hydroxylapatite, calcium 
triggers the osteoclast and osteoblast differently for the sake of bone formation. A higher 
serum concentration of calcium in the extracellular fluid will be detected by calcium-
sensing receptor (CaSR) to promotes the proliferation and differentiation of the osteoblast 
and hereafter bone formation. While osteoblast flourishes, osteoclast undergoes apoptosis 
56.  
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According to the recommended dietary allowance  (RDA) established by Food and 
Nutrition Board, Institute of Medicine, healthy Caucasian adults- males and females- 
between the ages of 20 to 50, the RDA for calcium is 1000 mg per day Table 2 57. For 
Asian Indians, on the other hand, the RDA for calcium is lower for the same age group. 
Healthy Asian Indian males and females are required to consume 600 mg per day to meet 
the RDA established by Indian Council of Medical Research (ICMR) in 2009 Table 3 58. 
The ICMR recommendation in 2009 is higher than the calcium RDA recommendation in 
2000, which was 400 mg per day. There has been some suggestion to revise and increases 
the RDA for Asian Indians given the high prevalence of vitamin D defsiceiy59.  The 
ICMR committee itself express its willingness to update the RDA once sufficient 
research studies are conducted to establish the new recommendation58. Dairy products are 
a good source of calcium, but other food items are rich in calcium as well Table 4 57  
TABLE 2 
Calcium Requirement According to Institute of Medicine. 57 
 
 
 
Age group Calcium requirement (milligram [mg] per day) 
Male 
19 - 30 years 1,000 
31 - 50 years 1,000 
    
 
 
Adapted from National Institutes of Health. Website. Available from 
https://ods.od.nih.gov/factsheets/Calcium-HealthProfessional/  
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TABLE 3 
Calcium Requirement According to Indian Council of Medical Research58 
 
 
 
Age group Calcium requirement (milligram [mg] per day) 
Men (≥ 19 years) 600 
    
 
 
Adapted from to Indian Council of Medical Research. Website. Available from 
http://icmr.nic.in/final/RDA-2010.pdf  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
24 
 
 
 
TABLE 4 
Food Sources of Calcium57 
 
 
 
Food items Calcium, (in milligram [mg]) 
per serving 
Yogurt, plain, low fat, 8 ounces 415 
Mozzarella, part skim, 1.5 ounces 333 
Sardines, canned in oil, with bones, 3 ounces 325 
Yogurt, fruit, low fat, 8 ounces 313–384 
Cheddar cheese, 1.5 ounces 307 
Milk, nonfat, 8 ounces 299 
Soymilk, calcium-fortified, 8 ounces 299 
Milk, reduced-fat (2% milk fat), 8 ounces 293 
Milk, buttermilk, low-fat, 8 ounces 284 
Milk, whole (3.25% milk fat), 8 ounces 276 
Tofu, firm, made with calcium sulfate, ½ cup 253 
Salmon, pink, canned, solids with bone, 3 ounces 181 
Cottage cheese, 1% milk fat, 1 cup 138 
Frozen yogurt, vanilla, soft serve, ½ cup 103 
Turnip greens, fresh, boiled, ½ cup 99 
Kale, fresh, cooked, 1 cup 94 
Ice cream, vanilla, ½ cup 84 
Chinese cabbage, bok choy, raw, shredded, 1 cup 74 
Bread, white, one slice 73 
Pudding, chocolate, ready to eat, refrigerated, 4 ounces 55 
 
 
 
Adapted from National Institutes of Health. Website. Available from 
https://ods.od.nih.gov/factsheets/Calcium-HealthProfessional/ 
 
2.4.2 Vitamin D 
Vitamin D is a fat-soluble vitamin and a steroid hormone. Sun exposure is a 
significant source of vitamin D. During the exposure to sunlight particularly ultraviolet B 
radiation, a vitamin D precursor in the skin, 7-dehydrocholesterol, is converted to 
previtamin D. Then, previtamin D transforms to vitamin D3. For achieving its biological 
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function, vitamin D3 undergoes two hydroxylation steps. One step is in the liver by 25-
hydroxylase and the second one is in the kidney by 1-alpha-hydroxylase. Also, fatty fish 
and fortified food and supplementations are the two other sources of vitamin D60.   
Vitamin D has important roles in calcium and phosphorus absorption in the small 
intestine and maintenance of calcium homeostasis. The proportion of dietary calcium 
absorbed increases from 10 - 15% to 30- 40% in the presence of adequate vitamin D. 
Similarly, the percentage of phosphorus absorbed is 80% in the presence of vitamin D but 
60% in case of vitamin D deficiency 60. Vitamin D enhances the absorption of calcium 
and phosphorus by opening the calcium channels in the small intestine and simulating the 
synthesis of the calcium binding protein. The calcium binding protein makes the 
environment favorable to absorb calcium and phosphorus and promotes bone 
mineralization.  In addition, vitamin D contributes to the maintenance of the of bone 
turnover rate,  and hence the incidence of fractures61. Osteopenia and osteoporosis could 
be caused or exacerbated by vitamin D deficiency61 Figure 2.  
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Figure 2: The Physiological Mechanisms of Osteopenia, Osteoporosis, and Fractures due 
to Vitamin D Deficiency. Adapted from Lips et al., 2011 61 
2.4.3 Protein 
Protein is a structural component of the bone; it contributes to the bone mass and 
bone volume by 33% and 50%, respectively 62. Adequate intake of protein is essential to 
compensate the protein that lost during the proteolysis in bone remodeling process in 
bone matrix. The interaction between dietary protein and bone could be summarized into 
four major roles. Firstly, adequate intake of protein facilitates calcium absorption in the 
small intestine. Calcium absorption is facilitated by the intake of protein or amino acid  
63. With low protein intake of < 0.8 gm/kg/day, the calcium absorption will be low. As a 
result, the PTH will be activated to start the bone resorption and release calcium from 
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bone63. Secondly, protein provides a structural unit to the bone matrix. Thirdly, adequate 
intake of protein enhances the concentration of Insulin-like Growth Factor 1 (IGF-1). 
Larsson et al. found a positive association between protein intake and the serum 
concentration of IGF-164. Finally, adequate protein intake maintains the muscle mass 
which works as a supportive and resistance against the fractures. Inadequate protein 
intake impacts the bone mass, strength and structure negatively even if adequate intake of 
calcium, vitamin D and other macronutrients are met 53. A diet high in protein has a 
positive impact on the bone mass and lowering fractures risk if the diet coupled with 
adequate intake of calcium62.    
2.4.4   Magnesium:  
Magnesium is one of the most abundant elements in the body. Specifically, 
magnesium takes rank 4 in term of its abundance in the body as a cation, and it makes a 
large contribution to the intracellular fluid in the body.  Bone holds approximately 50% 
to 60% of total body magnesium 65,66. Of that quantity, about one-third of bone 
magnesium is located in the cortical bone. Specifically, on the hydroxyapatite ’s surface 
or “in the hydration shell around the crystal” to be a reservoir of magnesium when it is 
needed15. The small intestine and kidney are the primary sites for magnesium absorption 
and excretion, respectively 67. Magnesium is a very active element in the body. To 
illustrate, it has a role in more than 300 metabolic reactions in the body. To name a view, 
it has a role in the protein, DNA, and RNA synthesis, production of the energy, 
reproduction, and others 68.  
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Magnesium is beneficial to bone mineral density.  Higher intake of magnesium- 
both from dietary sources and supplements- was associated with higher the whole body 
aBMD in White women and men (all p-value = 0.002). Ryder and colleagues concluded 
that there was an increase of 2% in the whole body aBMD with every increase in 
magnesium intake by 100-mg per day69. Dietary magnesium intake correlated positively 
with the aBMD at the trochanter (p-value < 0.05) in women and with the aBMD at the 
radius (p-value < 0.01) and trochanter (p-value < 0.05) in men 70.  New et al. reported that 
urinary pyridinoline and urinary deoxypyridinoline, markers of bone resorption, were 
correlated negatively with magnesium intake (all p-value < 0.005). Moreover, 
magnesium intake accounted for 12.3% in the variation of pyridinoline excretion and 
12.1% in the variation of deoxypyridinoline excretion 71.   
In a human culture of osteoblast, magnesium showed an enhancement of bone 
formation 72. As a structural component, lack of magnesium in bone formation impacts 
the size of hydroxyapatite crystals negatively by increasing the size of the crystals and 
makes the crystals well organized. Because of the better organization of the large 
crystals, the newly formed bone is fragile65 and less capable of bearing load.  Adequate 
presence of magnesium strengthens the bone by making the crystal small and not arrange 
correctly. Additionally, magnesium deficiency hinders the bone formation process by 
reducing the number and activity of osteoblast, while increasing the number of 
osteoclast65. Magnesium exerts another beneficial role in bone indirectly via the 
participation in calcium hemostasis. Hypomagnesemia decreases the release of PTH to 
the circulation when it is needed. In fact, PTH is the major stimulating factor to the 
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conversion of 25 (OH)D to the active form of vitamin D, which is 1.25 (OH2) D, in the 
kidney. With the lack of PTH and 1.25 (OH2) D, calcium absorption and bone 
mineralization65,73.   
Magnesium could be found in many animals and plant food items such as green 
leafy vegetables, whole grains, and nuts and seeds Table 5 74. Interestingly, the increased 
intake of magnesium will increase the intake of other nutrients important to bone as well 
such as calcium and phosphorus. There were positive correlations between the 
consumption of dietary magnesium and  the intake of other nutrients such as calcium (r = 
0.498, p-value < 0.001 )75, (r =0.64, p-value < 0.001)69 and (r = 0.319, p-value <0.001)76,  
phosphorus ( r = 0.58, p-value < 0.001)75, and (r = 0.285, p-value <0.001)76, potassium (r 
= 0.84, p-value < 0.001), and protein (r = 0.73, P < 0.001)69.  
For a healthy Caucasian between the ages 30 to 70, the RDA for magnesium 
ranges from 310 to 420 mg per day depending on the age and sex Table 677. For healthy 
Asian Indian male and females, RDA for magnesium is 340 mg and 310 mg, respectively 
Table 758. 
TABLE 5 
Food Sources of Magnesium74  
 
 
 
Food items Magnesium, (in milligram [mg]) per 
serving 
Rice bran, crude [118 gram (1.0 cup )] 922 
Molasses [337 gram (1.0 cup)] 816 
Seeds, pumpkin and squash seed kernels, dried [129 gram 
(1.0 cup)] 
764 
Mothbeans, mature seeds, raw [129 gram (1.0 cup)] 764 
Soybeans, mature seeds, raw [186 gram (1.0 cup)] 521 
30 
 
 
 
Seeds, sesame seeds, whole, dried [144 gram (1.0 cup)] 505 
Nuts, almonds, oil roasted, without salt added [157 gram 
(1.0 cup whole kernels)] 
430 
Cocoa, dry powder, unsweetened, processed with alkali 
[86 gram (1.0 cup)] 
409 
Nuts, cashew nuts, dry roasted, without salt added [137 
gram (1.0 cup halves and whole)] 
356 
Oats [156 gram (1.0 cup)] 276 
Peanuts, all types, dry-roasted, without salt [146 gram (1.0 
cup)] 
260 
Bulgur, dry [140 gram (1.0 cup)] 230 
Seeds, hemp seed, hulled [30 gram (3.0 tablespoons)] 210 
Nuts, walnuts, English [117 gram (1.0 cup, chopped)] 185 
Spinach, cooked, boiled, drained, without salt [180 gram 
(1.0 cup)] 
157 
Chard, swiss, cooked, boiled, drained, without salt [175 
gram (1.0 cup, chopped)] 
150 
Nuts, pistachio nuts, raw [123 gram (1.0 cup)] 149 
Beans, white, mature seeds, canned [262 gram (1.0 cup)] 134 
Nuts, pecans [109 gram (1.0 cup, chopped)] 132 
Lima beans, immature seeds, cooked, boiled, drained, 
without salt [170 gram (1.0 cup)] 
126 
Beans, black, mature seeds, cooked, boiled, without salt 
[172 gram (1.0 cup)] 
120 
Quinoa, cooked [185 gram (1.0 cup)] 118 
Milk, dry, whole, without added vitamin D [128 gram (1.0 
cup)] 
109 
Figs, dried, uncooked [149 gram (1.0 cup)] 101 
Beans, navy, mature seeds, cooked, boiled, without salt 
[182 gram (1.0 cup)] 
96 
Beans, black turtle, mature seeds, cooked, boiled, without 
salt [185 gram (1.0 cup)] 
91 
Rice, brown, medium-grain, cooked [195 gram (1.0 cup)] 86 
Beans, kidney, California red, mature seeds, cooked, 
boiled, without salt [177 gram (1.0 cup)] 
cup 85 
Potatoes, white, flesh, and skin, baked [1.0 potato large 
(3" to 4-1/4" dia)] 
81 
Chickpeas (garbanzo beans, Bengal gram), mature seeds, 
cooked, boiled, without salt [164 gram (1.0 cup)] 
79 
Millet, cooked [174 gram (1.0 cup)] 77 
31 
 
 
 
Kale, scotch, cooked, boiled, drained, without salt 
[130.gram (1.0 cup, chopped)] 
74 
Lentils, mature seeds, cooked, boiled, without salt [198 
gram (1.0 cup)] 
71 
Avocados, raw, California [230 gram (1.0 cup, pureed)] 67 
Chocolate, dark, 70-85% cacao solids [28.35 gram (1.0 oz 
)] 
65 
Sweet potato, cooked, boiled, without skin, with salt [328 
gram (1.0 cup, mashed)] 
59 
Raisins, seedless [165 gram (1.0 cup, packed)] 53 
Fish, tuna, light, canned in oil, drained solids [146 gram 
(1.0 cup, solid or chunks)] 
45 
 
 
 
Adapted from the United States Department of Agriculture (USDA) National Nutrient 
Database. Available from https://ods.od.nih.gov/pubs/usdandb/Magnesium-Content.pdf 
 
TABLE 6 
Magnesium Requirement According to Institute of Medicine  77 
 
 
 
Age group Magnesium RDA  (mg per a day) 
Male 
19 – 30 years 400 
31 – 50 years 420 
 
 
 
Adapted from National Institutes of Health. Website. Available from  
https://ods.od.nih.gov/factsheets/Magnesium-healthProfessional/  
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TABLE 7 
Magnesium Requirement According to Indian Council of Medical Research58 
 
 
 
Age group Magnesium RDA  (mg per a day) 
Men (≥ 18 years) 340 
 
 
 
Adapted from Indian Council of Medical Research. Website. Available from 
http://icmr.nic.in/final/RDA-2010.pdf  
 
 
2.5 The Difference in Body Composition Between Different Ethnicities  
BMI is widely used as a surrogate measure to define overweight and obesity and 
estimate fat mass (FM) because of its simplicity and practicality. A higher BMI 
associated with a higher likelihood of developing chronic diseases such as type 2 diabetes 
and cardiovascular diseases. BMI correlates positively with FM. As the FM increases, 
BMI increases, too because of the increase in the body weight 78. Based on this 
assumption, the fat-free mass is being ignored in the BMI calculation. A higher BMI 
might indicate a higher muscle mass, bone mass or FM mass, not just higher in FM. 
Interestingly, the body composition varies between ethnicities; therefore, the relationship 
between the BMI and percentage body fat (%BF) differs. The reasons for the discrepancy 
in the relationship are the difference in frame size, bone mass, and muscle mass between 
subjects from different ethnic groups.   
In general, Asians have higher %BF compared to their Caucasian counterparts. 
With a certain %BF, Asians have lower BMI by 3 to 4 points compared to the BMI for 
his/her Caucasian counterpart78. Within Asians, the %BF fat is not similar, too. Asian 
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Indians have the highest %BF compared to Chinese and Malays79. Therefore, many 
researchers investigated the difference in %BF between Asian Indian men and women 
compared to other ethnicities. Rush et al. found that Asian Indian men had a higher %BF 
than Europeans after adjusting for the weight and height (p-value = 0.02). With  29% as 
%BF of 29, the expected BMI was 30 kg/m2 in Europeans while the expected BMI  in 
Asian Indians was 25 kg/m2 26. High FM was seen in Asian Indian females compared 
Europeans 80,81. The tendency of higher FM in Asian Indians has been detected in the 
infancy. Asian Indian infants born in the United Kingdom had higher subscapular 
skinfolds compared to their White counterparts (p-value = 0.02). Stanfield and colleagues 
speculated that the higher subscapular skinfolds might be an indicator of the tendency to 
develop central obesity in later life in Asian Indians 82. 
On the other hand, fat-free mass was lower in Asian Indian adults26,80,81 and 
infants82 compared to Caucasians.  Appendicular Skeletal Muscle Mass (ASMM) is 
widely used to calculate the skeletal mass from the whole body DXA scan26,80,81.  Lower 
muscle mass has been reported in Asian Indian men26 and women 80,81. Ultimately, the 
Asian Indians have higher %BF compared to other ethnicities at any given BMI. World 
Health Organization (WHO) has endorsed a BMI cut-off for Asian population to 
accommodate for the variation in %BF and the higher tendency of Asians to develop type 
2 diabetes at a normal BMI category Table 8 83.  
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TABLE 8 
BMI for Asian Population Compared to International WHO Cut-off 83 
 
 
 
BMI strata WHO BMI cut-off Asian BMI cut-off 
Normal 18.5 – 24.9 18.5 – 22.9 
Overweight 25.0 – 29.9 23.0 – 27.4 
Obese class I 30.0 – 34.9 27.5 – 32.4 
Obese class II 35.0 – 39.9 32.5 – 37.4 
Obese class III ≥ 40.0 ≥ 37.5 
   
 
 
 Adapted from World Health Organization (WHO) Expert Consultation, 2004. 
 
2.6 The Relationship Between Body Composition and Areal Bone Mineral Density  
2.6.1 The Relationship Between Lean Mass and Areal Bone Mineral Density  
Many studies have been conducted to investigate the association between lean 
mass (LM) and areal bone mineral density (aBMD) in different ethnic groups and stages 
of life. Almost all the studies found that LM has a positive association with aBMD Table 
9. Of these studies, some authors concluded that LM correlated better with aBMD than fat 
mass and suggested that increasing LM to achieve PBM during young age or maintain 
aBMD during adulthood.  
2.6.1.1 The Mechanism of Interaction Between Lean Mass and Areal Bone Mineral 
Density   
The interaction between LM and bone is complex and involves many levels. Most 
importantly, the relationship between bone and LM starts with the mechanical load of the 
body weight.  An individual’s weight composes of the bone, muscle mass, and fat mass 
84. FM and LM both contribute to the gravitational load on the bone85. The kind of load is 
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called the static load, which is a result of higher body weight in general 86.  Accordingly, 
the bone will accommodate to this kind of stress in sake for stronger bone that can resist 
the load exerted on it 87. LM by itself also responsible for imposing a dynamic/ 
continuous load on the skeleton during muscle contraction 85,86. It has been believed that 
LM has a superior role on bone through the mechanical load since FM contributes by a 
small percent of body weight compared to LM. It has been estimated the contribution of 
the fat mass to total body weight in White men is16%43 - 27%44.  
Secondly, the relationship between LM and bone shares a genetic basis. Osteoblast 
and myocytes share the same cell precursor. They both differentiate from the 
mesenchymal stem cells 88. Also, there is pleiotropy between LM and bone. In other 
words, a single gene modifies the characteristics of both LM and bone simultaneously.  
Examples of these genes are GDF-8, MEF-2C, PGC-1alpha89. The effect of aging on LM 
and bone quality is a noticeable characteristic of the genetic interaction between LM and 
bone. The two systems are affected by aging in the same way. Sarcopenia, which is a 
decline in muscle mass, and osteoporosis are both results of ageing88.   
Finally, external factors such as sex hormones, estrogens and androgens, exert an 
impact on bone and muscle mass in the same manner. For example, the decline in serum 
testosterone concentration, which is an inevitable hallmark of aging, associated with a 
loss in aBMD and bone quality, and muscle mass and strength 
89-91. Amory and 
colleagues have shown that the administration of testosterone to seniors aged 65 years 
and older who had low serum testosterone concentrations improved their aBMD at the 
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lumbar spine (L1–L4) and total hip compared to placebo group over the study period of 
three years92.  
TABLE 9 
Summary of the Relationship Between Lean Mass and Areal Bone Mineral Density  
 
 
 
Authors  Study subjects  Variables  Major finding  
Douchi et al. 
93 
134 
postmenopausal 
Japanese women 
(45 exercising 
women and 89 
sedentary women) 
aged 50 to 60 yrs. 
aBMD (DXA) at the LS 
(L2 – L4) 
LM (kg) (DXA) 
LM positively associated 
with aBMD in the two 
groups.  But the strength of 
the association was higher in 
physically active women (r= 
.415, p-value <0.01) than in 
sedentary women (r=0.228, p 
<0.05)  
Palmer et al. 
85 
72 healthy men 
aged 20 to 81 yrs. 
aBMD (DXA) at LS (L2 
– L4), left FN, 
trochanter, and total hip 
and WB.  
LM (kg) and left leg 
LM (kg) (DXA) 
LM, and leg LM positively 
associated with aBMD all 
measured sites (all p <0.05). 
 
Cheng et al. 94 1465 and 1534 
healthy Chinese 
men and women, 
respectively aged 
20 to 96 yrs. 
aBMD (DXA) at the LS 
(L2 – L4), left FN and 
WB. 
LM (Kg) (DXA) 
LM positively associated 
with aBMD at all measured 
sites in men and women (all 
p <0.01) 
Shin et al. 95 3945 Korean men 
aged 20 years and 
older  
aBMD (DXA) at the LS 
(L1 – L4), FN and WB. 
LM (Kg) (DXA) 
LM positively associated 
with aBMD at all measured 
sites (all p <0.01) 
Bogl et al. 96 301 Finnish adults 
(154 men and 147 
aBMD (DXA) at the 
WB. 
LM positively associated 
with aBMD at WB in men 
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women) aged 23 to 
31 yrs. 
LM (kg) (DXA) and women after adjustment 
for height (all p < 0.01) 
Park et al. 97 1782 Korean adults 
(762 men and 1020 
women) aged 30 
yrs. and older  
aBMD (DXA) at the 
WB. 
LM (kg) (DXA) 
LM positively associated 
with aBMD at WB in men 
and women after adjustment 
for height others variables 
(all p < 0.05) 
Sotunde et 
al.98  
189 Urban black 
South African 
women aged 43 
yrs. and older  
aBMD (DXA) at FN, 
total hip of non-
dominant side and LS 
(L1 – L4) 
LM (kg) (DXA) 
LM positively associated 
with aBMD at the three sites 
after including FM, age and 
other variables in the 
regression model (all p < 
0.01)  
Wang et al. 99 951 women (317 
African American, 
154 Asians, 322 
Caucasians, 128 
Latinas) aged 20 to 
25 yrs.     
aBMD (DXA) at the 
WB, LS (L2 – L4) and 
left FN 
LM (kg) (DXA) 
LM positively associated 
with aBMD at WB, LS, and 
FN after controlling for 
ethnicity, age, FM and other 
covariates (all p < 0.05) 
EL Hage et 
al. 100 
70 Lebanese men 
ages 65 to84 yrs. 
aBMD (DXA) at the 
WB, total hip, FN, 
Ultra-distal radius and 
33% radius 
LM (kg) (DXA) 
LM positively associated 
with aBMD at all measured 
sites after controlling for age, 
height and FM (all p < 0.05) 
EL Hage et 
al. 101 
110 
postmenopausal 
Lebanese women 
aged 65 to 84 yrs. 
aBMD (DXA) at the 
WB, LS (L1–L4), total 
hip, FN, Ultra-distal 
radius and 33% radius 
LM (kg) (DXA) 
LM did not associate with 
aBMD at WB, total hip and 
FN after including fat mass 
and year since menopause in 
the regression model ( all p > 
0.05) 
Kirchengast 
and Huber 102 
282 healthy older 
adults (130 men 
aBMD (DXA) at the 
WB and FN 
LM positively associated 
with aBMD at WB and FN 
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and 152 women) 
aged 60 – 92 yrs.  
LM (kg) (DXA) after controlling for age, 
body weight and FM in men 
(all p < 0.01), but not in 
women (all p-value > 0.05) 
Zhao et al. 103 1085 Caucasian 
adults (538 men 
and 547 women) 
and 
 1988 Chinese 
adults (1110 men 
and 878 women) 
aged 19 yrs. and 
older  
aBMD (DXA) at the 
WB, FN and LS (L1 – 
L4) 
LM (kg) (DXA) 
LM positively associated 
with aBMD at WB, FN and 
LS after controlling for body 
weight, age and other 
variables in Caucasians and 
Chinese adults (all p < 0.05) 
Gómez-
Cabello et al. 
104 
223 seniors (64 
men and 159 
women) aged 65 to 
92 yrs.  
aBMD (DXA) at the 
WB, total hip, FN and 
LS (L1 – L4) 
LM (kg) (DXA) 
LM had positive associations 
with aBMD at all measured 
sites after controlling for age, 
FM, height and physical 
activity in women (all p-
value ≤0.01). In men, the 
positive association was only 
in LS and WB (all p < 0.05) 
Ho-Pham et 
al. 105 
210 
postmenopausal 
women aged 50 to 
85 yrs. 
aBMD (DXA) at the 
WB, FN and LS (L1 – 
L4) 
LM (kg) (DXA) 
LM positively associated 
with aBMD at all measured 
sites after controlling for age 
and FM (all p <0.05).  
Choi et al. 106 461 Korean adults 
(295 men and 166 
women) aged 21 to 
83 yrs. 
aBMD (DXA) at the 
total hip, FN and LS (L1 
– L4) 
LM (kg) (bioelectrical 
impedance analysis) 
LM positively associated 
with aBMD at all measured 
sites in men and women after 
controlling for body weight 
(all p <0.05) 
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Taes et al. 107 677 healthy men 
aged 25 to 45 yrs. 
aBMD (DXA) at the 
WB, total hip and LS 
(L1 – L4) 
LM (kg) (DXA) 
LM positively associated 
with aBMD at all measured 
sites after controlling for 
either body weight or FM (all 
p ≤0.01) 
Marwaha et 
al. 108  
1,045  
Healthy Asian 
Indian women 
aBMD (DXA) at the 
WB, total hip, FN, LS 
(L1 – L4) and 33 % 
radius  
LM (kg) (DXA) 
LM positively associated 
with aBMD at 33 % radius, 
WB and total hip after 
controlling for age, FM, 
serum 25OHD and PTH (all 
p <0.05) 
Hind et al. 109 352 (152 men and 
190 women)  
 
aBMD (DXA) at the left 
FN, and LS (L1 – L4) 
LM (Kg) (DXA) 
 
LM positively associated 
with LS aBMD in men only 
after controlling for body 
weight  (p < 0.05) 
 
 
 
Abbreviation: aBMD; areal bone mineral density, DXA; dual-energy x-ray 
absorptiometry, LS; lumbar spine, LM; lean body mass, FN; femoral neck, WB; whole 
body, FM; fat mass, 25OHD; 25-hydroxyvitamin D, PTH; Parathyroid hormone.  
 
 
2.6.2 The Relationship Between Fat Mass and Areal Bone Mineral Density 
An individual’s weight composes of the bone, muscle mass and fat mass 84.Fat mass 
has positive contributions to the aBMD through the mechanical load of body weight on 
the skeleton (the static load). Also, fat mass is responsible for the productions of certain 
hormone such as estrogen and leptin that promote bone health. On the other hand, fat 
mass is associated with an increase in inflammation and inflammatory cytokines that 
promote bone resorption such as Interleukin (IL-1) and tumor necrosis factor (TNF)86. 
Because of the complex relationship, the associations between fat mass and the aBMD 
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been examined in previous research studies were different Table 10. Some researchers 
found the association between fat mass and aBMD is a sex-dependent and age-dependent. 
In other words, a positive association was seen in postmenopausal women and older men, 
while the negative association observed in younger populations.  
TABLE 10 
Summary of the Relationship Between Fat Mass and Areal Bone Mineral Density  
 
 
 
Authors  Study subjects  Variables  Major finding  
Douchi et al. 
93 
134 
postmenopausal 
Japanese women 
aged 50 to 60 yrs. 
(45 exercising 
women and 89 
sedentary women) 
aBMD (DXA) at the LS 
(L2 – L4) 
FM (kg) (DXA) 
FM positively associated 
with aBMD only in sedentary 
women (r=.251, p <0.05) 
Cheng et al. 94 1465 and 1534 
healthy Chinese 
men and women, 
respectively aged 
20 to 96 yrs. 
aBMD (DXA) at the LS 
(L2 – L4), left FN and 
WB. 
FM (kg) and %BF (%) 
(DXA) 
FM negatively associated 
with aBMD at the LS in 
young men and positively 
with aBMD all measured 
sites in older men (all p 
<0.01) 
FM positively associated 
with aBMD at most of the 
measured sites in women (all 
p <0.01) 
%BF negatively associated 
with aBMD at most of the 
measured sites in men (all p 
<0.01) 
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%BF negatively associated 
with aBMD in young women 
and positively in 
postmenopausal women (all 
p <0.05).  
Shin et al. 95 3945 Korean men 
aged 20 yrs. and 
older   
aBMD (DXA) at the LS 
(L1 – L4), FN and WB. 
FM (kg), %BF (%) 
(DXA) 
FM and %BF negatively 
associated with aBMD at all 
measured sites (all p <0.01) 
after adjustment for body 
weight.   
Bogl et al. 96 301 Finnish adults 
(154 men and 147 
women) aged 23 to 
31 yrs.  
aBMD (DXA) at the 
WB. 
FM (kg) (DXA) 
FM positively associated 
with aBMD at WB in both 
men and women after 
adjustment for height (all p < 
0.05) 
Park et al. 97 1782 Korean adults 
(762 men and 1020 
women) aged 30 
yrs. and older  
aBMD (DXA) at the 
WB. 
FM (kg) (DXA) 
FM positively associated 
with aBMD at WB in both 
men and women after 
adjustment for height others 
variables (all p < 0.05) 
Sotunde et 
al.98  
189 Urban black 
South African 
women aged 43 
yrs. and older  
aBMD (DXA) at FN, 
total hip of non-
dominant side and LS 
(L1 – L4) 
FM (Kg) (DXA) 
FM did not associate with 
aBMD at three sites after 
including LM, age and other 
variables in the regression 
model (all p >0.05)  
Wang et al. 99 951 women (317 
African American, 
154 Asians, 322 
Caucasians, 128 
Latinas) aged 20 to 
25 yrs.     
aBMD (DXA) at the 
WB, LS (L2 – L4) and 
left FN 
FM (Kg) (DXA) 
FM positively associated 
with aBMD at WB, LS, and 
FN after controlling for 
ethnicity, age, LM and other 
variables (all p < 0.05) 
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EL Hage et 
al. 100 
70 Lebanese men 
ages 65 to 84 yrs. 
aBMD (DXA) at the 
WB, LS (L2 – L4), total 
hip, FN, Ultra-distal 
radius and 33% radius 
FM (Kg) and %BF (%) 
(DXA) 
FM did not associate with 
aBMD at all measured sites 
after controlling for age, 
height and LM (all p > 0.05) 
EL Hage et 
al. 101 
110 
postmenopausal 
Lebanese women 
aged 65 to 84 yrs. 
aBMD (DXA) at the 
WB, LS (L1–L4), total 
hip, FN, Ultra-distal 
radius and 33% radius 
FM (Kg) (DXA) 
FM positively associated 
with aBMD at WB, total hip 
and FN after including LM 
and year since menopause in 
the regression model ( all p ≤ 
0.01) 
Kirchengast 
and Huber 102 
282 healthy older 
adults (130 men 
and 152 women) 
aged 60 to 92 yrs.  
aBMD (DXA) at the 
WB and FN 
FM (Kg) (DXA) 
FM positively associated 
with aBMD at WB and FN 
after controlling for age, 
body weight and LM in 
women (all p < 0.01), but not 
in men (all p > 0.05) 
Zhao et al. 103 1085 Caucasian 
adults (538 men 
and 547 women) 
and 
 1988 Chinese 
adults (1110 men 
and 878 women) 
aged 19 years and 
older  
 
aBMD (DXA) at the 
WB, FN and LS (L1 – 
L4) 
FM (Kg) and %BF (%) 
(DXA) 
FM and %BF negatively 
associated with aBMD at 
WB, FN and LS after 
controlling for body weight, 
age and other variables in 
Caucasians and Chinese 
adults (all p < 0.01) 
Gómez-
Cabello et al. 
104 
223 seniors (64 
men and 159 
women) aged 65 to 
92 yrs.  
aBMD (DXA) at the 
WB, total hip, FN and 
LS (L1 – L4) 
FM (Kg) (DXA) 
FM negatively associated 
with aBMD at the WB after 
controlling for age, LM, 
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height and physical activity 
in men (p < 0.01) 
Ho-Pham et 
al. 105 
210 
postmenopausal 
women aged 50 to 
85 yrs. 
aBMD (DXA) at the 
WB, FN and LS (L1 – 
L4) 
FM (Kg) (DXA) 
FM positively associated 
with aBMD at FN and LS 
after controlling for age and  
LM (all p <0.05).  
Choi et al. 106 461 Korean adults 
(295 men and 166 
women) aged 21 to 
83 yrs. 
aBMD (DXA) at the 
total hip, FN and LS (L1 
– L4) 
FM (kg) (bioelectrical 
impedance analysis) 
FM negatively associated 
with aBMD at all measured 
sites in men, except for total 
hip in men and women after 
controlling for body weight 
(all p <0.05) 
Taes et al. 107 677 healthy men 
aged 25 to 45 yrs. 
aBMD (DXA) at the 
WB, total hip and LS 
(L1 – L4) 
FM (kg) (DXA) 
FM negatively associated 
with aBMD at all measured 
sites after controlling for 
either body weight or LM 
(all p ≤0.01) 
Hind et al. 109 352 (152 men and 
190 women)  
 
aBMD (DXA) at the left 
FN and LS (L1 – L4) 
FM (kg) (DXA) 
 
FM did not associate with 
aBMD either in men or 
women after controlling for 
body weight  (all p > 0.05) 
 
 
 
Abbreviation: aBMD; areal bone mineral density, DXA; dual-energy x-ray 
absorptiometry, LS; lumbar spine, FM; fat mass, FN; femoral neck, WB; whole body, 
LM; lean body mass, % BF; percent body fat. 
  
2.6.3 The Relationship Between Visceral Adipose Tissue and Subcutaneous Adipose 
with Areal Bone Mineral Density  
In recent years, the attention has shifted from total body fat toward fat distribution in 
the body because abdominal/central adiposity had been associated with insulin resistance 
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and increase the risk of cardiovascular disease110 rather than the total body fat.  
Abdominal fat contains visceral fat, or intra-abdominal fat, and subcutaneous fat. The 
visceral Adipose tissue is in the mesentery and omentum regions. This kind of fat is 
completely different from subcutaneous adipose tissue regarding secretion of hormones 
and peptides, function, adipocytes size, and blood vascularity and innervations. Due to 
these differences, visceral adipose tissue is a risk factor for insulin resistance, type 2 
diabetes and cardiovascular diseases110. The relationship between bone density and fat 
had been dedicated to investigating the difference between the visceral adipose tissue and 
subcutaneous adipose tissue with bone density.    
The association between visceral adipose tissue and subcutaneous adipose tissue with 
aBMD has been investigated in adults, adolescents, diabetic subjects and in different 
ethnic groups. The findings, however, are inconsistent. The findings can be categorized 
into negative association106,111-114 and lack of association109,115 between visceral adipose 
tissue and bone density Table 11, while the range of finding is higher in the association 
between subcutaneous adipose tissue and aBMD Table 12.  The positive association seen 
in many studies106,114 between visceral adipose tissue and aBMD was eliminated or 
became negative after controlling for some confounders such as body weight and age. 
This shows the statistical handling of the data could be a source of the variation in 
findings. The method as well selected to calculated visceral adipose tissue could play a 
significant role in the inconsistency. Salimzadeh and colleague 115 used the bioelectrical 
impedance analysis (BIA) to estimate the visceral adipose tissue. In fact, the model of 
BIA used in that study only estimates the trunk fat percentage.  Abdominal fat contains 
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both visceral adipose tissue and subcutaneous adipose tissue 116. As a result, the results of 
the study did not investigate the genuine relationship between visceral adipose tissue and 
aBMD accurately.   
TABLE 11 
Summary of The Relationship Between Visceral Adipose Tissue and Areal Bone Mineral 
Density 
 
 
      
Authors  Study subjects  Variables  Major finding  
Salimzadeh et 
al. 115 
95 overweight and 
obese women aged 
30 to 50 yrs. 
aBMD (DXA) at the LS 
(L2 – L4) and FN  
VAT (%) (bioelectrical 
impedance analysis) 
VAT did not associate with 
aBMD either at LS or FN 
after controlling  for age, 
marital status, number of 
children and occupation (all 
p >0.05) 
Campos et al. 
111 
125 obese 
adolescents (45 
boys and 80 girls) 
aged 14 to 18 yrs. 
 
aBMD (DXA) at the 
WB   
VAT (cm) (Abdominal 
ultrasound) 
VAT negatively associated 
with aBMD at spine only in 
boys (p = 0.03) 
Choi et al. 106 461 Korean adults 
(295 men and 166 
women) aged 21 to 
83 yrs. 
aBMD (DXA) at the 
total hip, FN and LS (L1 
– L4) 
VAT (cm2) (Computed 
tomography) 
VAT negatively associated 
with aBMD at all measured 
sites in men and women after 
controlling for body weight, 
age and other variables (all p 
<0.05) 
Hind et al. 109 352 (152 men and 
190 women)  
aBMD (DXA) at the left 
FN and LS (L1 – L4) 
VAT (gm) (DXA) 
VAT did not associate with 
aBMD in men or women  
after controlling for body 
weight  (p > 0.05) 
46 
 
 
 
Russell et al. 
112 
30 girls (15 obese 
and 15 normal 
weight) aged 12 to 
18 yrs.  
aBMD (DXA) at the 
WB, total hip and LS  
VAT (cm2) (magnetic 
resonance imaging) 
 
VAT negatively associated 
with aBMD at the WB in the 
whole sample and with 
aBMD at the  LS only in 
obese girls  (all p =0.04) 
Katzmarzyk 
et al. 113 
1081 adults (444 
African American 
men, and women 
and 637 White men 
and women) aged 
18 to 74 yrs.  
aBMD (DXA) at the 
WB 
VAT (cm2) (Computed 
tomography) 
 
VAT negatively associated 
with aBMD at the WB after 
controlling for age, LM and 
SAT in all groups except for 
African American women 
and White men (all p < 0.05)  
Yamaguchi et 
al. 114 
312 diabetic 
Japanese adults 
(187 men [aged 28 
to 83 yrs.] and 125 
postmenopausal 
women [aged 46 to 
82 yrs.])  
aBMD (DXA) at the 
WB, LS, FN and 33% 
radius  
VAT (cm2) (Computed 
tomography)  
VAT negatively associated 
with aBMD at WB and 33% 
radius in women only after 
controlling for body weight 
(all p < 0.05) 
 
 
 
Abbreviation: aBMD; areal bone mineral density, DXA; dual-energy x-ray 
absorptiometry, LS; lumbar spine, FN; femoral neck, VAT; visceral adipose tissue, WB; 
whole body, SAT; subcutaneous adipose tissue 
 
TABLE 12 
Summary of the Relationship Between Subcutaneous Adipose Tissue and Areal Bone 
Mineral Density  
 
 
     
Authors  Study subjects  Variables  Major finding  
Campos et al. 
111 
125 obese 
adolescents (45 
aBMD (DXA) at the 
WB   
SAT positively associated 
with aBMD at lower limb in 
boys (p < 0.01) 
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boys and 80 girls) 
aged 14 to 18 yrs. 
SAT (cm) (Abdominal 
ultrasound) 
Choi et al. 106 461 Korean adults 
(295 men and 166 
women) aged 21 to 
83 yrs. 
aBMD (DXA) at the 
total hip, FN and LS (L1 
– L4) 
SAT (cm2) (Computed 
tomography) 
SAT negatively associated 
with aBMD at LS only in 
men after controlling for 
body weight, age and other 
variables (p-value =0.035) 
Russell et al. 
112 
30 girls (15 obese 
and 15 normal 
weight) aged 12 
to18 yrs.  
aBMD (DXA) at the 
WB, total hip and LS  
SAT (cm2) (magnetic 
resonance imaging) 
SAT positively associated 
with aBMD at the WB and 
LS in the whole sample  (all 
p <0.05) 
Katzmarzyk 
et al. 113 
1081 adults (444 
African American 
men, and women 
and 637 White men 
and women)  
aBMD (DXA) at the 
WB 
SAT (cm2) (Computed 
tomography) 
 
SAT did  not associate with 
WB aBMD after controlling 
for age, LM and VAT in any 
of the four groups (all p > 
0.05)  
Yamaguchi et 
al. 114 
312 diabetic adults 
(187 men [aged 28 
to 83 yrs.] and 125 
postmenopausal 
women [aged 46 to 
82 yrs.])  
aBMD (DXA) at the 
WB, LS, FN, 33% 
radius  
SAT (cm2) (Computed 
tomography)  
SAT negatively associated 
with aBMD at WB and FN in 
men and 33% radius in 
women after controlling for 
body weight (all p < 0.05) 
 
 
 
Abbreviation: aBMD; areal bone mineral density, DXA; dual-energy x-ray 
absorptiometry, SAT; subcutaneous adipose tissue, FN; femoral neck, LS; lumbar spine, 
WB; whole body, VAT; visceral adipose tissue.  
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CHAPTER 3: PROTOCOL AND METHODS 
3.1 Protocol 
3.1.1 Participants  
3.1.1.1 Inclusion criteria 
A participant who fulfilled all the following requirements was eligible to take part in 
the study:  
1. Male who was either Asian Indian or Caucasian  
a. Asian Indian participants were defined themselves as natives of first or 
subsequent generation immigrants who can trace their ancestry to any 
country of the Indian subcontinent. These countries are India, Bangladesh, 
Nepal, Pakistan and Sri Lanka. 
b. Caucasian participants were defined themselves as non-Hispanic who did 
not belong to any other ethnic group 
2. Age between 20 to 50 years 
3. Free of the chronic diseases or medications that might affect bone metabolism    
4. Signed informed consent 
3.1.1.2 Exclusion criteria: 
A participant who had health conditions, or on medications that might impact his 
body composition or bone outcomes was not eligible for the study. The exclusion criteria 
were:    
1. Participants with cancer or cancer therapy in the past six months 
2. Participants with kidney disease or kidney stones in the past year 
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3. Participants with immune disease or on steroid drugs to suppress immunity 
4. Participants with unmanaged thyroid disease 
5. Participants with a heart attack or stroke within the past year 
6. Participants with arthritis taking prednisone 
7. Participants with liver disease 
8. Participants on osteoporosis medication 
3.1.2 Study Design 
This was a cross-sectional study with a single visit. The entire visit did not take 
more than 2 hours. The timeline of the study is illustrated below Figure 3. The data that 
was collected during the visit will be explained in a data collection section.     
  
 
 
Figure 3: Study Timeline 
3.1.3 Study Groups  
The study had two groups Figure 4. The first group was composed of Asian 
Indian men.  The second group was composed of Caucasian participants  
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Figure 4: Study Groups 
3.1.4 Sampling Techniques 
Convenience sampling was the type of sampling method for the study. The 
sample of the study was composed of individuals who were interested in and eligible for 
participating in the study.  
3.1.5 Research Location and Space  
The bone lab on the third floor of 3 Parkway Building (1601 Cherry St. 
Philadelphia, PA 19102) was the location, to which the participants came. At this place, 
informed consent was signed by the participant, and research assistants collected 
information about anthropometrics measurements and dietary intakes using food 
frequency questionnaires and 24-hour recall. The second location was a room (203) on 
the second floor of 3 Parkway Building (1601 Cherry St. Philadelphia, PA 19102) for 
doing the DXA scans. A research assistant was responsible for escorting the subject to 
move from the third to second floor.   
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3.1.6 Recruitment 
The recruitments of participants for the study was through research flyers that 
were disseminated to Drexel University's University City and Center City 
Campus Appendix 1 and via word-of-mouth. The flyers were proved by the Institutional 
Review Board (IRB). The flyer contained information about the study written in simple 
language. The research objective, eligibility criteria, compensation fee and the email 
address of the project and phone number and location of the lab were the information in 
the flyer. Interested participants called the lab phone number or sent an email to the email 
project, which were in the flyers.  
3.1.7 Screening   
A research assistant conducted a telephone eligibility questionnaire Appendix 2 
for participants who were interested in the study.  During the phone call, details 
explaining the study’s objective, procedures and the duration of the visit were discussed 
with the participant. The research assistant confirmed the participant’s eligibility by 
asking for a brief medical history form, medications and treatments currently being 
used, and no exclusion criteria present. Once the participant agreed to participate in the 
study, an in-person appointment was scheduled at the Bone Lab (1601 Cherry 
Street Room 317, Philadelphia, PA 19102). Each participant received $30 monetary 
compensation at the end of his visit to incentivize people to participate in the study. 
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3.2 Data Collection 
3.2.1 Informed Consent Form  
The study participant arrived at the laboratory, and a research assistant began with 
the informed consent process Appendix 3. The research assistant gave time for the 
participant to read the informed consent at his own pace. After that, the research assistant 
verbally explanation major points in the informed consent including the principal 
investigator and institutional review board contact information and the objectives of 
conducting the study. Two identical copies of the informed consent were signed and 
dated by the research assistant and the participant. One copy of the signed informed 
consent was given to the participant, while the other kept in the participant’s file. 
3.2.2 Demographics 
 Participant’s demographic information including information about age, 
ethnicity, contact information and tobacco and alcohol consumptions and others was 
collected during the visit. The information was self-reported by the participants 
Appendix 4.   
3.2.3 Medical History 
The participant was asked to complete a medical history form Appendix 4. The 
form had questions about disease history, tobacco, and alcohol use, eating disorder 
diagnosis, recent and current medications and supplements intake, any medical 
comments, and any recent weight loss/gain greater than 10 lbs. 
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3.2.4 Anthropometrics Measurements 
3.2.4.1 Weight and Height 
A stadiometer with a balance beam scale (Seca 700 Physician's Balance Beam 
Scale, Chino, CA, USA) was used to measure the height (Inches) and weight (Pounds 
[lbs.]) while participants were with minimal and light clothes, without shoes, and without 
anything heavy in his pocket. One of the research assistants administered the 
measurements procedures, while the other research assistant recorded the data Appendix 
5. The weight and height were reported to the nearest 0.25 lb and 0.25 inches, 
respectively.  
3.2.4.2 Waist Circumference 
Using a non-stretchable measuring tape (Health Mobius® Circumference (Girth) 
measuring Tape-Body Tape Measure), a research assistant took three measurements of 
participant’s waist circumference in inches. One of the research assistants administered 
the measurements procedures, while the other research assistant recorded the data 
Appendix 5. The measurements were taken around trunk one inch above the umbilicus. 
The average of the three measurements took and reported to the nearest 0.25 inches.  
3.2.5 Dietary Information and Physical Activity  
3.2.5.1 Magnesium Food Frequency Questionnaire (Mg-FFQ) 
A magnesium food frequency questionnaire (Mg-FFQ) Appendix 6 was 
developed by the principal investigator of this study. The principal investigator and her 
undergraduate seniors in Nutrition Department at Drexel University are conducting 
research to validate the MgFFQ against fourteen days food diary record117. The Mg-FFQ 
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contained a list of 33 food items that have magnesium content ranged from 6 mg to 178 
mg per serving. Participants were asked to approximately quantify the number of 
servings and frequency of consumption per day, week, or month. Visual demonstrations 
of the measuring cups were provided to guide the participant in the process of specifying 
the amount.  
FFQs are widely used in the research to assess the intake of specific food groups 
or nutrients. A review by Cade et al. demonstrated that 166 out of 223 studies included in 
the review, about 74% of the studies, used the FFQ to assess the consumption of nutrients 
118. It has been found that FFQs are considered a practical tool to evaluate the dietary 
intake 119.  
3.2.5.2 Calcium Food Frequency Questionnaire (Ca-FFQ) 
A calcium food frequency questionnaire (Ca-FFQ) Appendix 7 was taken from 
“calcium calculator” by International Osteoporosis Foundation website 120, which was 
developed by a pharmaceutical company, called Takeda. The Ca-FFQ contained 80 food 
items, and the content of calcium ranged from 7 mg to 445 mg per serving. Participants 
were asked to approximately quantify the number of servings and frequency of 
consumption per day, week, or month. Visual demonstrations of the measuring cups were 
provided to guide the participant in the process of specifying the amount.  
3.2.5.3 Twenty-Four Hour Dietary Recall  
A research assistant administered twenty-four-hour diet recall Appendix 8 to 
calculate energy and macronutrients. The participants were asked to remember and report 
his food intake for the day preceding the day of the visit to the best of his abilities.  The 
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research assistant followed the 5-Step Multiple-Pass Approach. The analysis of the 
twenty-four-hour diet recall was completed using the foodWorks software (FoodWorks ® 
version 17 Copyright © 2015) A self-estimated approach of physical activity level was 
used to quantify the level of physical activity.   
3.2.6 Dual Energy X-ray Absorptiometry  
In this study, the Dual-energy x-ray absorptiometry (DXA) scan was used to 
measure areal bone mineral density (aBMD) and body composition of the participants. 
The use of DXA scan has many advantages encouraging researchers and clinicians to use. 
The advantages of DXA are 1) low level of radiations a subject gets during the scan 
compared to Computer Tomography (CT), 2) the easiness of setting up of the subject for 
the scan, 3) the shortness of the scan 121 and 4) the images have high resolution122.  There 
are two beams of X-ray each one had a different energy to give an estimated measure of 
the bone and soft tissue. The underline principle of DXA is that the absorption of the 
ionized radiation DXA emits by bone is proportional to the amount of bone29. As a result, 
the dense bone will absorb more radiation than small bone.  DXA (Lunar iDXA, 
enCORE Software Version 17, GE Healthcare, United Kingdom)  was used to measure 
the aBMD. To check the validity and reliability of the DXA, a research assistant 
calibrated the DXA on the same day and before scanning each participant.  A quality 
control phantom box was used during the calibration process. The level of radiation a 
participant was exposed to during the scan is minimal, and it had been estimated to be 
less than the radiation a person will be exposed to during a cross-country flight.  
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Before doing the scan, the participant was asked to remove all jewelry, metals in 
his clothes such as a zipper, and remove his shoes.  A patient gown with back ties was 
provided to a participant who had metal on his clothes. The participant was instructed to 
lie on the DXA bed inside the box printed on the DXA table. The measurements of 
aBMD were taken at the lumbar spine (L2 - L4), dual femoral neck, 33% radius (a 
proximal third of the radius) of the nondominant hand and whole body.   
DXA divides the whole-body scan intro three distinct parts, which are bone 
mineral content, fat mass, and bone-free mass. Also, enCORE Software Version 17 is 
capable of measuring regional fat distribution in the android region and gynoid region. 
DXA defines the region of interest (ROI) for android fat as “lower boundary at pelvis cut, 
upper boundary above pelvis cut by 20% of the distance between pelvis and neck cuts 
and  lateral boundaries are the arm cuts” and for gynoid fat as “upper boundary below the 
pelvis cut line by 1.5 times the height of the android ROI and lateral boundaries are the 
outer leg cuts123.”Figure 5 
Moreover, enCORE Software Version 17 has been supplemented with software to 
measure the visceral adipose tissue in the abdominal region or android region. The ability 
of DXA’s enCORE Software to measure visceral adipose tissue had been validated with 
the measurements of visceral adipose tissue taken by computed tomography in subjects 
age between 18 to 90 years with BMI between 18.5 to 40 kg/m2. Person correlations of 
visceral adipose tissue by DXA and computed tomography were 0.973, 0.979, and 0.978 
for men, women, and total sample, respectively 124.   
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For body composition analysis, the following variables were derived from whole 
body scan 1)  total lean mass (lb), 2)  total body fat mass (lb), 3)  android fat mass (lb), 4) 
gynoid fat mass (lb),  5) visceral adipose tissue (lb) and 6) subcutaneous adipose tissue 
(lb).   
DXA calculates the aBMD at any site as  
𝐵𝑜𝑛𝑒 𝑀𝑖𝑛𝑒𝑟𝑎𝑙 𝐶𝑜𝑛𝑡𝑒𝑛𝑡 (𝑔𝑚)
𝑃𝑟𝑜𝑗𝑒𝑐𝑡𝑒𝑑 𝐴𝑟𝑒𝑎 (𝑐𝑚2)
 and  aBMD is 
expresed as (gm/cm2) 31. Carter et al. stated that taller subjects will have higher aBMD 
compared to shorter subjects eventhough they have simlar volumetric bone denisty29. 
Given the fact that Caucasians are taller and hevier than Asias Indain subjects23,25,27,80,125, 
aBMD will be lower in Asian Indians becsue of their short stataure. As a way to eliminate 
that artifact, Carter and collueges have suggested to use Bone Mineral Apparent Density 
(BMAD) in gm/ 𝑐𝑚3 . BMAD was caluacted as  
𝑎𝐵𝑀𝐷 (
𝑔𝑚
𝑐𝑚2
)
𝐻𝑒𝑖𝑔ℎ𝑡 (𝑚)
 .  BMAD is an estimate of 
the volumetic bone mineral desnity based on aBMD
29.     
 
 
 
Figure 5: Region of Interest for Android and Gynoid Fat. Adapted from GE Healthcare 
Lunar. 2016 123 
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3.2.7 Data Management  
The documents that were used for collecting the participants’ information were 
stored in a locked drawer for the PI in the secured room which had a security code only 
known by the research team. The room was on the third floor of 3 Parkway Building 
(1601 Cherry St. Philadelphia, PA 19102).  On a computer that linked to the encrypted 
server, a research assistant entered the participants’ information into a Microsoft® Excel 
data sheet.  Then, Statistical Package for the Social Sciences (SPSS) version 24 (IBM 
Corp., Armonk, NY, 2016) was used to run the statistical tests.  
3.3 Statistical Analysis 
Descriptive statistics, including means, standard deviations were calculated for the 
total sample and Asian Indian and Caucasian men for variables that were normality 
distributed. For non-normally distributed variables, median and interquartile range were 
calculated. Because age and BMI have an impact on aBMD, the Asian Indians and 
Caucasians were matched for age and BMI. Since the age and BMI were not normality 
distributed within ethnic groups, Mann Whitney U test was used to compare our age and 
BMI between the two groups Non-significant differences between Asian Indians and 
Caucasians for age and BMI were found, which confirmed that two groups were 
adequately matched. Data was analyzed using IBM SPSS Statistics software (version 24, 
IBM Corporation, Armonk, NY). 
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3.3 Analyses for Specific Aims  
3.3.1 Statistical Analyses for Specific Aim 1 
The aBMD at all skeletal sites were normally distributed in Asian Indians and 
Caucasians according to Shapiro-Wilk test. Therefore, independent sample t-test was 
used to determine whether a difference exists in aBMD for the whole body, and at the 
lumbar spine (L2 -L4), femoral neck or 33% radius of the non-dominant hand between 
Asian Indian and Caucasian men matched for age and BMI. The independent variable 
was ethnicity, which was treated as a dichotomous variable.  
3.3.2 Statistical Analyses for Specific Aim 2 
Lean mass was normally distributed in Asian Indians and Caucasians according to 
Shapiro-Wilk test. Therefore, independent sample t-test was used to determine whether a 
difference exists in total lean mass between Asian Indian and Caucasian men matched for 
age and BMI. The independent variable was ethnicity, which was treated as a 
dichotomous variable. However, the gynoid fat mass and android fat mass were not 
normally distributed in Asians Indians and Caucasians. As a result, Mann Whitney U test 
was used to determine whether a difference exists in android fat mass or gynoid fat mass 
between Asian Indian and Caucasian men matched for age and BMI.   
3.3.3 Statistical Analyses for Specific Aim 3 
Daily calcium and magnesium intakes were not normally distributed in Asians 
Indians and Caucasians according to Shapiro-Wilk test. As a result, Mann Whitney U test 
was used to determine whether a difference exists in calcium or magnesium intake 
between Asian Indian and Caucasian men matched for age and BMI.   
60 
 
 
 
3.3.4 Statistical Analyses for Specific Aim 4 
In the overall sample, lean mass, aBMD at the lumbar spine (L2- L4) and aBMD at 
the femoral neck were normally distributed according to Shapiro-Wilk test. The 
associations between 1) lean mass and aBMD at the lumbar spine (L2- L4) and 2) lean 
mass and aBMD at the femoral neck were performed using Pearson product-moment 
correlation coefficients. Android fat mass and gynoid fat mass were not normally 
distributed in the overall sample; therefore, the associations between 1) android fat mass 
and aBMD at the lumbar spine (L2- L4); 2) android fat and aBMD at the femoral neck; 3) 
gynoid fat mass and aBMD at lumbar spine (L2- L4); and 4) gynoid fat mass and aBMD at 
the femoral neck were performed using Spearman rank order correlation coefficient.   
Lean mass, android fat mass and gynoid fat mass were not normally distributed in 
Asian Indians and Caucasians according to Shapiro-Wilk test; therfore, the assoications 
between 1) lean mass and aBMD at the lumbar spine (L2- L4) in Asian indians and 
Caucasians ; 2) lean mass and aBMD at the femoral neck in Asian indians and Caucasians 
; 3) android fat mass and aBMD at the lumbar spine (L2- L4) in Asian indians and 
Caucasians; 4) android fat and aBMD at the femoral neck in Asian indians and 
Caucasians; 5) gynoid fat mass and aBMD at lumbar spine (L2- L4) in Asian indians and 
Caucasians ; and 6) gynoid fat mass and aBMD at the femoral neck in Asian indians and 
Caucasians were perfomed using Spearman rank order correlation coefficient.   
 For comparing the relationships between body composition variables and aBMD 
in Asian Indian and Caucasian men matched for age and BMI, the 
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Fisher’s r to z transformation was used.  If the Z score ≤ - 1.96 or ≥ 1.96, that indicates 
the two correlations were significantly different at the p < 0.05 level.  
3.3.5 Statistical Analyses for Exploratory Aim 1 
Chi-square contingency table test was used to determine whether a difference 
exists in the percentage of Asian Indian men who met the daily RDA for calcium 
established for Asian Indian men by Indian Council of Medical Research and the 
percentage of Caucasian men who met the daily RDA for calcium established by the 
Institute of Medicine.  The two variables were the ethnicity, either Asian Indian male or 
Caucasian male, and meeting the criterion of daily calcium RDA, either meeting the 
RDA or not meeting the RDA.  
3.3.6 Statistical Analyses for Exploratory Aim 2 
The visceral adipose tissue was normally distributed in Asian Indians and 
Caucasians according to Shapiro-Wilk test. Therefore, independent sample t-test was 
used to determine whether a difference exists in visceral adipose tissue between Asian 
Indian and Caucasian men matched for age and BMI. The independent variable was 
ethnicity, which was treated as a dichotomous variable. However, subcutaneous adipose 
tissue was not normally distributed in Asians Indians and Caucasians. Mann Whitney U 
test was used to determine whether a difference exists in subcutaneous adipose tissue 
between Asian Indian and Caucasian men matched for age and BMI.   
3.3.7 Statistical Analyses for exploratory Aim 3 
The BMAD at all skeletal sites were normally distributed in Asian Indians and 
Caucasians according to Shapiro-Wilk test. Therefore, independent sample t-test was 
62 
 
 
 
used to determine whether a difference exists in BMAD for the whole body, at the lumbar 
spine (L2 -L4), femoral neck or 33% radius of the non-dominant hand between Asian 
Indian and Caucasian men matched for age and BMI. The independent variable was 
ethnicity, which was treated as a dichotomous variable.  
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INTRODUCTION 
  
Osteoporosis is a public health concern in the United States and around the globe. 
The burden of osteoporotic fracture entails financial, physical and psychosocial aspects. 
Annually, approximately $10 to $15 billion is the financial cost that is directed to 
hospitals’ care for subjects with osteoporotic fractures in the United States1. With the 
increase in life expectancy, the proportion of the elderly population is expected to 
increase. Aging is a risk factor for osteoporosis and hence osteoporotic fractures. During 
the last three decades, there has been an increase in hip fractures by 2 to 3 times in Asian 
countries. It has been estimated that more than half of the osteoporotic fractures will 
occur in Asian countries by 2050 2. Even though the prevalence of osteoporosis in men is 
lower than in women, the expected increase in the percentage of numbers of cases with 
hip fracture in men is 89% compared to 69% in women during the period between 2000 
to 2025 3. The mortality rate in men is higher due to osteoporosis and osteoporotic 
fractures compared to women in developed and developing countries such as India4,5.  
Low areal bone mineral density (aBMD) is considered a strong risk factors for 
future fracture risk. The aBMD is different between people from different ethnic groups. 
Asian Indians have lower aBMD compared to Caucasians
6-8. In fact, body composition 
and the intake of specific nutrients contribute to the bone mass. For example, lean mass 
correlated positively with aBMD
9-12, but findings were inconsistent regarding the 
association between fat mass and aBMD
10-13. Previous studies have been shown that body 
composition differs between subjects from different ethnic groups. Asian Indians have 
higher body fat, and visceral adipose tissue and subcutaneous adipose tissue, but lower 
65 
 
 
 
muscle mass compared to Caucasians14-18. Regarding the role of diet in bone mass,  
dietary intake plays a crucial role in optimizing peak bone mass, maintaining of bone 
mass and protecting against the regular load imposed on bone 19. One of the well-known 
nutrients for acquiring and maintaining bone mass is calcium. Even though Asian Indians 
have lower aBMD, their calcium RDA is lower than the RDA established for their 
Caucasian counterparts20,21.  
The primary aim of the current study was to examine the difference in aBMD 
between healthy Asian Indian immigrants and Caucasians matched for age and body 
mass index (BMI) using cross-sectional study design. Also, the differences in body 
composition and dietary intake between the two groups were appraised in the study.  In 
addition, the correlation between lean amass and regional fat distributions with aBMD at 
the lumbar spine and femoral neck were evaluated in the overall sample and within each 
ethnic group.   
SUBJECTS AND METHODS 
Subjects  
Healthy males who self-identified themselves as either Asian Indians or 
Caucasians from Philadelphia community were recruited for this cross-sectional study. 
Participants were healthy and did not have any medical conditions that might interfere 
with bone or body composition outcomes. Subjects diagnosed with diseases known to 
interfere with bone metabolism or body composition were excluded. The study was 
approved by the Institutional Review Board of Drexel University and informed consent 
was obtained from each participant.  
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Bone Mass and Density Measurements 
For each participant, there were four values of aBMD (gm/cm
2) at whole body, 
lumbar spine (L2-L4), dual femoral neck and 33% radius of the non-dominant hand 
measured by dual-energy X-ray absorptiometry (DXA) (Lunar iDXA, United Kingdom). 
From the whole-body scan, total lean mass (lb), android fat mass (lb) and gyroid fat mass 
(lb).  Measurements of visceral adipose tissue (lb) and subcutaneous adipose tissue (lb) 
were recorded for only 12 participants out of 32 because the software used to measure 
these fat compartments had not installed at the beginning of the study. Participants 
completed medical history form which induced information about age, medical 
conditions, medications and supplements taking recently. All scans taken were in 
accordance with the standard protocol for positioning the participants. Also, quality 
control procedure was performed according to the guidelines set by DXA manufacturer. 
The coefficient of variation of repeated measures of the aBMD at the lumbar spine, 
femoral neck and total body is 1.0%22, which indicates high precision level. The 
difference in skeletal size between Asian Indians and Caucasians has been considered as 
one of the possible causes for lower aBMD in Asian Indians compared to Caucasians
23-25.  
To eliminate that artifact, Carter and colleagues have suggested using Bone Mineral 
Apparent Density (BMAD) in gm/ 𝑐𝑚3. BMAD was calculated as a𝐵𝑀𝐷 (𝑔𝑚/𝑐𝑚2)/ 
(𝐻𝑒𝑖𝑔ℎ𝑡 (𝑚)). BMAD is an estimate of the volumetric bone mineral density based on 
aBMD
26.  
   
67 
 
 
 
Anthropometrics Measurements 
Anthropometrics measurements of weight and height were measured while 
participants were with minimal and light clothes and without shoes to the nearest 0.25 lb 
and 0.25 inches, respectively using a stadiometer with a balance beam scale (Seca 700 
Physician's Balance Beam Scale, USA). Average of three waist circumference 
measurements around the torso one inch above the umbilicus the nearest 0.25 inch was 
reported. Body mass index (BMI) was calculated by dividing weight over height and 
expressed as kg/m2.  
Diet information  
Diet history was collected using two food frequency questionnaires (FFQ), one 
for calcium by International Osteoporosis Foundation27, while the other for magnesium28. 
The FFQ was used to give an estimate of the consumption of food that is rich in either 
calcium or magnesium over the past six months. Participants were asked to 
approximately quantify the number of servings and frequency of consumption per day, 
week or month. Visual demonstrations of the measuring cups were provided to guide the 
participant in the process of specifying the amount was consumed. The daily intake of 
calcium and magnesium were calculated from FFQs. Additionally, 24-hour food recall 
was administered to calculate energy and macronutrients. The food recall was analyzed 
using FoodWork software (FoodWorks ® version 17 Copyright © 2015)  
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Statistical analysis 
Data was analyzed using SPSS 24 (IBM Corp., Armonk, NY, 2016). Means and 
SDs were calculated for all continuous variables of anthropometric measurements, bone 
density, body composition and nutrient intake that were normally distributed and median 
and interquartile range (IQR) for non-normally distributed variables. The level of 
significance was set at P 0.05 in 2-tailed testing, which is a commonly used value in 
previous similar research. The differences between Asian Indians and Caucasians in all 
continuous variables were tested by performing Independent sample t-test for normally 
distributed variables and Mann-White U for non-normally distributed outcomes. For 
comparing the difference in the percentages of categorical variables between Asian 
Indians and Caucasians, Chi-square test contingency table was performed.  To test the 
association between the body composition variables and bone density at the lumbar spine 
and femoral neck, Pearson product-moment correlation coefficient was used for normally 
distributed variables and Spearman's rank correlation coefficient when Pearson product-
moment correlation coefficient’s assumptions had not met.  
RESULTS  
Demographic and anthropometric measurements for the Asian Indians and 
Caucasians are presented in Table 13. A sample of 32 males was included in the analysis 
of the study. Sixteen subjects self-identified themselves as Asian Indian and 16 males 
self-identified themselves as Caucasians. There was no significant difference between the 
two groups in age. The median age was 25 years for Asian Indians and 28 years for 
Caucasians, U=123, p = 0.85. For the anthropometric measurements, Asian Indians have 
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significantly lower body weight, U= 59, p = 0.01, and short stature, U = 44.5, p < 0 .01, 
compared to Caucasians.  However, there was no difference in the BMI between groups 
U= 100, p 0.29.  Out of the 16 Asian Indians, there were 6 participants in the normal 
weight category, 7 participants in the overweight category and 3 participants in obese 
category according to the BMI cut off for Asian population29. Out of the 16 Caucasians, 
there were 7 participants in the normal weight category, 5 participants in the overweight 
category, and 4 participants obese category according to the international BMI cut off 
established by World Health Organization 29. There were no differences in the percentage 
of normal weight, overweight and obese between the two ethnic groups χ2 (2, n=32) 
=0.55, p = 0.76). Asian Indians had a lower average mean waist circumference (34.05 ± 
5.62 inches) compared to Caucasians (36.43 ± 4.46 inches) (t (30) = -1.33, p =0.20. There 
was no difference in the proportion of Asian Indians and Caucasians with central 
adiposity according to the waist circumference measurements χ2 (1, n=32) =1.39, p = 
0.24.   
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TABLE 13 Demographics Characteristics and Anthropometrics Measurements by Ethnic 
Groups a -g 
 
 
 
Variables Asian Indians Caucasians P value 
Age (years) 25.00 (9.0) 28.00 (10.0) 0.85 a 
Weight (lb.) 157.88 (38.56) 185.88 (60.63) 0.01* a 
Height (inches) 67.13 (4.19) 72.13 (4.10) <0.01* a 
BMI (kg/m2) 24.91 (4.63) 25.42 (5.02) 0.29 a 
Normal Weight Category n (%) b 6.0 (37.5) 7.0 (43.8) 
0.76e Overweight Category n (%)c 7.0 (43.8) 5.0 (31.3) 
Obese Category n (%)d 3.0 (18.8) 4.0 (25) 
Waist Circumference (inches) 34.05 ± 5.62 36.43 ± 4.46 0.20f 
Central Adiposity n (%)g 6.0 (37.5) 3.0 (18.8) 0.24e 
 
 
 
Values are Mean ± SD or Median (interquartile range)  
* p ≤ 0.05 indicates a significant difference between groups 
a Mann Whitney U test  
b Normal weight category of BMI for Asian Indians ranges between 18.5 – 22.9 kg/m2 
and for Caucasians ranges between 18.5 – 24.9 kg/m2  
c Overweight category of BMI for Asian Indians ranges between 23.0 – 27.4 kg/m2 and 
for Caucasians ranges between 25.0 – 29.9 kg/m2 
d Obese category for BMI for Asian Indians ranges between 27.5 – 35 kg/m2 and for 
Caucasians ranges between 30.0 – 35 kg/m2 
e Chi-square contingency table test 
f Independent Sample T-test.   
g Central adiposity is defined with waist circumference ≥ 35 inches in Asian Indians and 
≥ 40 inches in Caucasians    
Abbreviation: lb; pound, kg; kilogram, m2; meters squared. 
Bone Outcomes  
Areal bone mineral density, bone mineral content (BMC) and BMAD for Asian 
Indians and Caucasians are presented in Table 14.  The aBMD at the lumbar spine, 
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femoral neck and 33% radius of the non-dominant hand were slightly lower in Asian 
Indian males compared to Caucasians; however, none of them were significant at p 
<0.05. A trend p-value toward significance was found in the aBMD at the whole body. 
Means aBMD at the whole body were 1.23 ± 0.13 gm/cm
2 in Asian Indians and 1.34 ± 
0.12 gm/cm2 in Caucasians t (30) = -1.88, p 0.07. BMC at all measured sites were 
significantly lower in Asian Indians than Caucasians, p < 0.05 except for the femoral 
neck. There was a trend toward significance in the BMC at the femoral neck t (30) = -
1.92, p 0.07. None of the BMAD at any sites measured were significantly different 
between the two groups, p >0.05.    
 TABLE 14 
Areal Bone Mineral Density, Bone Mineral Content, and Bone Mineral Apparent Density 
by Ethnic Groups  
 
 
 
Variables Asian Indians Caucasians P value 
aBMD (gm/cm2) 
Whole Body 1.26 ± 0.13 1.34 ± 0.12 0.07 
Lumbar Spine (L 2- L 4) 1.26 ± 0.18 1.35 ± 0.18 0.15 
Femoral Neck 1.13 ± 0.15 1.16 ± 0.18 0.58 
33% Radius 0.99 ± 0.08 1.00 ± 0.09 0.75 
BMC (gm) 
Whole Body 2878.75 ± 375.90 3419.69 ± 512.62 <0.01 * 
Lumbar Spine (L 2- L 4) 56.33 ± 10.21 71.21 ± 16.41 <0.01* 
Femoral Neck 5.91 ± 0.83 6.63 ± 1.27 0.07 
33% Radius 2.53 ± 0.36 2.81 ± 0.40 0.04* 
BMAD (gm/cm3) 
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Whole Body 0.72 ± 0.07 0.73 ± 0.06 0.81 
Lumbar Spine (L 2- L 4) 0.73 ± 0.11 0.74 ± 0.08 0.80 
Femoral Neck 0.65 ± 0.09 0.63 ± 0.08 0.51 
33% Radius 0.57 ± 0.05 0.55 ± 0.05 0.13 
 
 
 
All values are Mean ± SD  
* p ≤0.05 indicates a significant difference between groups  
Abbreviation: aBMD; areal bone mineral density, gm; grams, cm
2; centimeters squared, 
BMC; bone mineral content, BMAD; bone mineral apparent density, cm3; centimeters 
cubic.  
Body Composition Outcomes  
The differences in body composition variables between Asian Indians and 
Caucasians are presented in Table 15.  There were no significant differences between 
Asian Indians and Caucasians for total fat mass, android fat mass, gynoid fat mass, 
visceral adipose tissue and subcutaneous adipose tissue, p > 0.05. A significant difference 
was found in the lean mass. Asian Indians have lower lean mass (122.43 ± 18.88 lb.) 
compared to Caucasians (137.89 ± 19.14 lb.) (t (30) = -2.31, p = 0.03.          
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TABLE 15 
Body Composition Outcomes by Ethnic Groups a-c  
 
 
 
Variables Asian Indians Caucasians P value 
Lean Mass (lb) 122 .43 ± 18.88 137.89 ± 19.14 0.03*a 
Fat Mass (lb) 46.75 (19.18) 49.60 (18.98) 0.62 b 
Android Fat Mass (lb) 3.80 (2.55) 4.00 (2.55) 0.46 b 
Gynoid Fat Mass (lb) 7.60 (2.95) 8.20 (3.58) 0.49 b 
Android Fat Mass /Gynoid Fat 
Mass Ratio 
0.49 ± 0.11 0.50 ± 0.11 0.83 a 
Visceral Adipose Tissue (lb)c 0.89 ± 0.65 1.68 ± 1.03 0.14 a 
Subcutaneous Adipose Tissue (lb)c 1.88 (2.43) 2.20 (1.85) 0.42 b 
 
 
 
Values are Mean ± SD or Median (interquartile range)  
* p <0.05 indicates a significant difference between groups 
a Independent Sample T-test 
b Mann Whitney U test 
c Variables were measured only for 12 participants out of the 32 participants 
Abbreviation: lb; pound 
 
Dietary Intake Outcomes  
The differences in nutrient intake between Asian Indians and Caucasians are 
presented in Table 16. The caloric intake per day was similar between Asian Indians and 
Caucasians t (30) = 0.14, p =0.89. The calories consumed per weight was slightly higher 
in Asian Indians (27.98 ± 10.85 kcal/kg) than Caucasians (23.61 ± 6.60 kcal/kg), but it 
was not significant p= 0.18. There were no significant differences between groups for 
protein, carbohydrates, fat, calcium, magnesium and vitamin D, p >0.05. Thirteen 
(81.3%) Asians Indians met calcium’s RDA by the Indian Council of Medical Research 
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while only 9 (56.3%) Caucasians met calcium's RDA by Institute of Medicine, χ2 (0, 
n=32) =2.33, p = 0.13. 
TABLE 16 
 Dietary Intakes by Ethnic Groups a-d  
 
 
 
Variables Asian Indians Caucasians P value 
Calories (kcal) 2169.5 ± 947.7 2127.9 ± 694.8 0.89a 
Calories/ Weight (kcal/kg) 28.0 ± 10.9 23.6 ± 6.6 0.18a 
Carbohydrates (gm) 249.6 ± 139.9 235.4 ± 82.7 0.73a 
Protein (gm) 111. 5 ± 59.9 98.4 ± 44.9 0.49a 
Protein/ weight (gm/kg) 1.3 (1.4) 1.0 (0.7) 0.31b 
Fat (gm) 79.5 ± 36.7 75.9 ± 41.4 0.8a 
Calcium (mg) 1102. 6 (722.3) 937.2 (623.9) 0.16b 
Meeting RDA n (%)c 13 (81.3) 9 (56.3) 0.13d 
Vitamin D (mcg) 1.2 (3.5) 0.6 (3.5) 0.81b 
Magnesium (mg) 255.3 (238.2) 243.6 (199.7) 0.88b 
 
 
 
Values are presented as Mean ± SD or Median (interquartile range)  
* p ≤0.05 indicates a significant difference between groups 
a Independent Sample T-test 
b Mann Whitney U test.  
c Calcium RDA for Asian Indians is 600 mg /day and 1000 mg/day for Caucasians 
d Chi-square contingency table test 
Abbreviation: Kcal; kilocalories, Kg; kilograms, gm; grams, mg; milligrams, mcg; 
micrograms.  
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Correlation between body composition and Areal Bone Mineral Density  
The correlation between body composition and aBMD are provided in Table 17. 
A Spearman's rank correlation between lean mass and aBMD at the lumbar spine was 
statistically significant in the overall sample (r= 0.44, p =0.01). However, within each 
ethnic group, the positive relationship between lean mass and aBMD at the lumbar spine 
was not evident, p >0.05. Regarding the association between lean mass and aBMD at the 
femoral neck, no associations were found in the overall sample, p= 0.097, or Asian 
Indians, p = 0.47. However, a positive association was revealed in Caucasians (r= 0.53, p 
= 0.03) between lean mass and aBMD at the femoral neck. 
Android fat mass had negative associations, though insignificant, with aBMD at 
the lumbar spine and femoral neck at the overall sample. Caucasians maintained the 
negative, insignificant association between android fat and aBMD at the lumbar spine (r= 
- 0.26, p =0.33) and aBMD at the femoral neck (r= -0.05, p= 0.85) when they were 
analyzed as a group. Asian Indians showed a site-specific relationship between android 
fat and aBMD. A negative association was shown between android fat and aBMD at the 
femoral neck (r= -0.05, p= 0.85), while insignificant positive association with aBMD at 
the lumbar spine (r= 0.12, p= 0.67).  
Gynoid fat was not associated with any of aBMD sites in the overall sample or 
within each group. Interestingly, gynoid fat has a positive association with aBMD at the 
lumbar spine (r=0.06) while the negative association with aBMD at the femoral neck (r= - 
0.03) in the overall sample. None of the association was significant at the alpha level of 
0.05.  Asian Indians showed a similar site-specific association between gynoid fat and 
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aBMD. On the other hand, Caucasians showed negative, insignificant association between 
gynoid fat and aBMD at the lumbar spine and femoral neck.  
The comparison of the correlations between body composition and aBMD at the 
lumbar spine and femoral neck was listed in Table 18. Fisher z transformation was 
performed to compare the relationships between each variable of the body composition 
with aBMD at the lumbar spine and femoral neck between Asian Indians and Caucasians.  
A z score of more than 1.96 or less than -1.96 shows a significant difference in the 
correlation between the two groups at the alpha level of 0.05. No significant difference 
was found in the correlation between body composition variables and aBMD at the 
lumbar spine and femoral neck between Asian Indians and Caucasians. 
 
 
 
 
 
 
 
 
 
 
77 
 
 
 
TABLE 17 
Correlation Coefficients Between Body Composition Variables and Areal Bone Mineral 
Density a-b 
 
 
 
Variables Groups 
Lean Mass 
(lb) 
Android Fat Mass 
(lb) 
Gynoid Fat 
Mass (lb) 
r P value r P value r 
P 
value 
Lumbar 
Spine  
(L2- L4) 
Total Sample 
N=32 
0.44 a 0.01* -0.02 a 0.90 0.06 a 0.77 
Asian Indians 
n=16 
0.35b 0.19 0.12 a 0.67 0.15 a 0.57 
Caucasians 
n=16 
0.44 b 0.09 -0.26 a 0.33 -0.16 a 0.57 
Femoral 
Neck 
Total Sample 
N=32 
0.30 a 0.10 -0.19 a 0.92 -0.03 a 0.89 
Asian Indians 
n=16 
0.20 b 0.47 -0.05 a 0.85 -0.03 a 0.92 
Caucasians 
n=16 
0.53 b 0.03* -0.05 a 0.85 -0.11 a 0.70 
 
 
 
* p <0.05 indicates a significant correlation   
a Spearman's rank correlation coefficient 
b Pearson product-moment correlation coefficient 
Abbreviation: aBMD; areal bone mineral density, gm; grams, cm
2; centimeter, lb.; pound, 
r; correlation coefficient  
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TABLE 18 
Comparing the Strength of the Correction between Body Composition Variables and 
Areal Bone Mineral Density by Ethnic groups  
 
 
 
Variables Asian Indians Caucasians 
Z score P value 
aBMD 
(gm/cm2) 
Body Composition 
(lb) 
r r 
Lumbar Spine 
(L2 - L4) 
Lean Mass 0.35 0.44 -0.28 0.78 
Android Fat 0.12 -0.26 0.98 0.33 
Gynoid fat 0.15 -0.16 0.79 0.43 
Femoral Neck 
Lean Mass 0.20 0.53 -1.01 0.31 
Android Fat -0.05 -0.05 0.00 1.00 
Gynoid fat -0.03 -0.11 0.20 0.84 
 
 
 
* p ≤ 0.05 indicates a significant difference in the correlations between Asian Indians and 
Caucasians  
Abbreviation: aBMD; areal bone mineral density, gm; grams, cm
2; centimeter, Ib.; pound, 
r; correlation coefficient  
 
DISCUSSION   
Our findings indicate that aBMD and BMAD at all measured sites were similar, 
between Asian Indians and Caucasians. However, BMC was lower in Asian Indians 
compared to Caucasians at the four skeletal sites.  Lean mass was the only significant 
difference between groups in term of body composition. Lean mass was lower in Asian 
Indians compared to age and BMI matched Caucasians. In addition, there was no 
difference in daily calcium and magnesium intakes between Asian Indians and 
Caucasians.  
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Bone Outcomes Differences 
  Other researchers have observed similar results in findings no difference 
between immigrant Asian Indians and Caucasians in their aBMD 
15,30-33. Interestingly, the 
mean aBMD at all skeletal sites observed in our study was higher than the values reported 
from normative data of aBMD for Asian Indian living in India 
6,7,34. On the contrary to the 
findings reported by the present study, previous studies found that Asian Indians have 
lower aBMD compared to Caucasians
6,7,34. The variance of the studies protocol could be 
the reason for such difference in findings. Some of these investigations used National 
Health and Nutrition Examination Survey (NHANES) III data to compare the difference 
in aBMD between Asian Indians and Americans 
6.  In fact, NHANES III data was 
composed of three different ethnic groups, which were non-Hispanic White, non-
Hispanic black and Mexican Americans.  As a result, the use of NHANES III without 
excluding other ethnic groups artificially magnifies difference in aBMD between 
Caucasians and Asian Indians. A similar approach was taken by Marwaha et al. of 
comparing the aBMD between Asian Indians and  US reference data provided by DXA 
manefauactures35. Shivane et al. used reference data for Caucasians only and found Asian 
Indians have lower aBMD than Caucasians
8. The failure to detect such difference by our 
study could be attributed to the difference in dietary protein and calcium intakes by Asian 
Indians seen in the present study, which is higher than what has been reported before for 
Asian Indians living in India 8,36. The mean protein intake reported in the study was close 
to the mean protein intake reported by other researchers from military personnel 35,37, 
who failed to find a difference in aBMD between Asian Indians and Caucasians. Higher 
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protein intake enhances bone density by being a structural component of the bone and 
enhancing the concentration of Insulin-like Growth Factor 1 (IGF-1) 38. Our data revealed 
the similarity in aBMD between young Asian Indian immigrants and Caucasians.    
 The significant difference in BMC at all skeletal sites between the two ethnic 
groups noticed in this study agrees with previous studies15-17. Since both aBMD and BMC 
are influenced by the skeletal size39,  both outcomes might be artificially low in Asian 
Indians than Caucasians if the former group are shorter. As a result, in the current study, 
the approach of eliminating the dependence of aBMD on frame size was by using BMAD.  
Our data revealed the lack of significant difference in the BMAD between the Asian 
Indians and Caucasians in all measured skeletal sites, which supported by other studies 
conducted in both sexes,  males15,30,40 and females23,32,41.  
Dietary Intakes 
Our data showed that Asian Indians tended to consume more calcium per day 
compared to Caucasians. Despite the lack of statistical difference in mean calcium intake 
between Asian Indians and Caucasians, most of Asian Indians met Calcium’s RDA but 
Caucasians did not. However, the percentage of participants meeting Calcium’s RDA did 
not differ between the two ethnic groups. The calcium intake reported from the What We 
Eat In America, NHANES 2009-2011 showed that the average intake of males met the 
RDA42, but the current study found that Caucasians consumed less calcium per day and 
did not meet their calcium’s RDA of 1000 mg/day. Interestingly, in the current study, the 
calcium intake by Asian Indians was similar to what has been reported on Asian Indians 
for military personals37 and slightly higher than reported in Asian Indian in the United 
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States36, but dramatically higher than the general Asian Indian population8. Shatrugna et 
al. found lower intake of calcium by Asian Indians women from low socioeconomic 
status43. The difference in the findings could be due to the sex difference between the two 
studies’ sample. In general, men consume more calories and thus, micronutrients than 
women do. The economic status and the degree of urbanization would play a role as well. 
The daily intake of calcium among healthy Asian Indian males age 20 to 29 years from 
upper socioeconomic status was 1194 ± 513.1 mg/day6.  As evidence of the effect of 
urbanization on a diet, Asian Indian residents in urban areas consumed more calcium than 
Asian Indian resident in rural areas because of the obvious change in macronutrient 
partitioning 44. In Asian Indian community, the higher the socioeconomic status is, the 
higher consumption of calories and the education level are 45. These could apply to the 
Asian Indians in the United States as well and justify why there was higher consumption 
of protein and calcium among Asian Indians. In our sample, both Asian Indians and 
Caucasians failed to meet the magnesium’s RDA. The finding for Asian Indians was 
similar to the finding by Shah et al. They found that the intake of magnesium was 240 ± 
129 mg day in young healthy Asian Indian in the United States 36. Data from NHANES 
for 1999-200046 and 2001–201447 are congruent with our findings of magnesium intake 
by Caucasians. We found no difference in calcium or magnesium intakes between young 
Asian Indians and Caucasians.  
Body Composition  
The findings from the current study confirmed the significant difference in lean 
mass between Asian Indians and Caucasians seen by others 16,48-50. With regard to the fat 
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mass difference, previous investigations have shown that Asian Indians have higher 
abdominal fat mass compared to Caucasians despite similar or lower circumference of the 
former group51.  The current study, however, found no differences in android and gynoid 
fat, and visceral and subcutaneous adipose tissue. As a result, the findings from current 
study disagreed with ample of evidence which found that Asian Indians have higher total 
fat mass and regional fat mass compared to Caucasians.  Nevertheless, there were some 
studies supporting the absence of difference in subcutaneous adipose tissue and visceral 
adipose tissue measured by the gold standard technique, Magnetic Resonance Imaging,  
between Asian Indians and Europeans 48. The current study found that Caucasians have 
insignificant higher visceral adipose tissue compared to Asian Indians which was seen by 
others 48,50. We had the measurements of visceral adipose tissue and subcutaneous 
adipose tissue for 12 participants only. Among this small subgroup, the median waist 
circumference was higher in Caucasians than Asian Indians, and the trend p-value was 
close to significance, although the difference was not significant (p= 0.078).  The lack of 
difference in visceral and subcutaneous adipose tissue could be because the mean waist 
circumference for Asian Indians in the current study was slightly lower compared to what 
had reported by others 48,52 and their Caucasian counterparts in the present study. In 
addition, the Caucasian males recruited in this study had slightly higher BMI and age 
compared to Asian Indians. The difference in the fat distribution between Asian Indians 
and Caucasians may be become more evident with higher BMI48 and in older age. 
Another reason which explains the lack of difference in fat mass in the present study is 
that we measured the fat mass, gynoid and android mass as a mass without adjusting 
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these values for body weight.  Previous study has shown that the fat mass itself did differ 
between Asian Indians and Europeans, but after adjustment for body height and weight, it 
became significantly higher in Asian Indians 17.  Our data showed that Asian Indians had 
lower lean mass than Caucasians, but no difference in android or gynoid mass was 
detected.    
The Association Between Body Composition and Areal Bone Mineral Density  
It was found in the present study that positive associations between lean mass 
with aBMD at the lumbar spine in the overall sample and aBMD at the femoral neck in 
Caucasian participants only. The correlation coefficients were positive but not significant 
for Asian Indians. Country to our findings on Asian Indians, previous investigators have 
shown a significant positive effect of lean mass on aBMD at the lumbar spine and femoral 
neck in a large sample size 53. Similar findings were observed by other researchers in 
different ethnic groups11,12,54-56.  The reason behind the lack of any significant positive 
correlation with aBMD is the low lean mass in Asian Indians. In like manner,  meta-
analysis has shown that the effect of lean mass on aBMD is much stronger in men than 
women because of the higher lean mass in the former group 57. Furthermore, the positive 
effect of lean mass on aBMD is diminished by sedentary lifestyle
11.  Previous works have 
found Asian Indians have lower levels of physical activity compared to Caucasians30,58. 
The level of physical activity might be another reason for detecting the positive 
association between lean mass and aBMD with small sample size in Caucasians but not in 
Asian Indians.  
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The lack of association between fat mass and aBMD was the results of this study.  
Some researchers found positive association54,56,59,60, while other found negative 
association11,12,53,54,61 or lack of the association at all11,54,55,59. The inconsistency in 
findings is due to the complex relationship between fat mass and aBMD. The association 
between fat mass and aBMD is influenced by a sex
39, age11, ethnicity, skeletal sites and 
the stage of bone mass-bone maintenance or bone loss11. Cheng et al. found men aged 20 
to 50 years did not benefit from the fat mass, while older men did11. Also, Bogl et al. 
claimed that the presence of multiple confounding variables in the association between 
fat mass and aBMD such as diet, socioeconomic status, genetic and environmental factors 
and physical activity make the association between fat mass and aBMD inconsistent 
62. At 
the cellular level, with the recognition of fat mass as an active endocrine organ, fat mass 
secretes active metabolites and hormones involved in the bone metabolism whether 
favorably such as 17-estradiol or negatively such as inflammatory cytokines63,64.  
Furthermore, osteoblast and adipocyte cells are originated from the same progenitor in 
the bone marrow, which is the mesenchymal stem cell 63-65. The differentiation of 
mesenchymal stem to either cell is influenced by some cytokines secreted by adipocytes 
66.   
  The current study examined the association between regional fat distribution and 
aBMD, which was investigated by few researchers. However, most of the studies focused 
on the relationship between total fat mass and aBMD. We used the advantages of DXA to 
measure regional fat distribution to gauge visceral adipose tissue by measuring android 
fat and subcutaneous adipose tissue by measuring gynoid fat. Our data revealed mixed 
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finding between gynoid fat and aBMD, but none of them were significant.  Previous 
investigations showed negative 67,68 positive 69,70 or lack of association71 between 
subcutaneous adipose tissue and aBMD.  Most of the previous works showed a negative 
relationship between visceral adipose tissue and aBMD 
67-71. The findings seen in the 
current study partially agreed with previous findings; however, none of the associations 
were significant.  The lack of significance was due to the use of an indirect approach to 
measuring visceral adipose tissue.  The android fat measured in this study contained both 
visceral adipose tissue and subcutaneous adipose tissue. The visceral and subcutaneous 
adipose tissue are distinct fat compartments. They differ in the secretion of hormones and 
peptides, function, adipocytes size, blood vascularity and innervations and risk of 
developing chronic diseases72. Our data showed no association between android or 
gynoid fat with aBMD in Asian Indians or Caucasians.  
 Despite the lack of significant difference in the correlation between body 
composition with aBMD in Asian Indians and Caucasians, the differences in the direction 
of the association between android and gynoid fat with aBMD were noticed between 
Asian Indians and Caucasians raise a flag to consider ethnic-specific understanding of the 
association between body composition and aBMD.  
            The current study has several strengths. First, a unique perspective was used by 
comparing bone outcomes, dietary intake and body composition in healthy young Asian 
Indian immigrants in the United States with Caucasians matched for age and BMI in a 
single study. Second, the two groups were matched based on age and BMI to control for 
those confounding variables while comparing the difference in bone and body 
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composition and testing the correlations between body composition and aBMD. That was 
done because both variables have their influences on the primary outcomes of the current 
study. Additionally, the lean mass was assessed independently from the bone mass. In 
other words, we measured bone-free lean mass which a limitation in some of the previous 
investigations. Also, the calcium and magnesium intakes were assessed using food 
frequency questionnaires to capture the intake of these nutrients over six months, which 
matches the rate of bone mineral density turnover. 
            The study has some limitations. Firstly, the physical activity was not measured 
using an objective and valid assessment tool. The assessment of physical activity in the 
study was limited to a self-reported level of physical activity in the 24 hours preceding 
the day of collecting all measurements. Physical activity positively influences both lean 
mass and bone density, especially during bone accrual stage. As a result, physical activity 
could be confounding variables for the associations between body composition and 
aBMD. Additionally, the study did not investigate inflammatory cytokines and bone 
turnover markers, which could add a new dimension in understating some aspect of bone 
quality. Finally, we did not distinguish between first and second generation Asian Indian 
immigrants. This may have been important because second-generation immigrant might 
undergo through the acclimatization to food, environmental risk factors, health awareness 
and access to health care which is not could be not common for first-generation 
immigrants. Finally, the study had a small sample, which may have limited certain 
variables from reaching statistical significance. However, the current experimental 
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research aimed to set the stage for future studies in understanding the impact of body 
compositions on aBMD of Asian Indian and Caucasian men. 
  Conclusion 
            Our data indicates that there were no differences in aBMD, calcium and 
magnesium intakes between healthy young Caucasians and Asian Indians in the United 
States. However, Asian Indians have markedly lower lean mass compared to Caucasians. 
Since the scope of this study was limited to examine the difference in bone density using 
aBMD, the study highlights the need for further research to examine the variability in 
bone turnover between immigrant Asian Indians and Caucasians to see if the findings 
from biochemical outcomes and bone density are similar.   
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Appendix 1 
 
 
 
Recruiting Volunteers for a Research Study 
Bone and Metabolic syndrome study 
Research Objective 
To determine the relationship between bone health and metabolic syndrome 
outcomes  
Who is eligible? 
You should be a South Asian or Caucasian male between ages 20-
50 years. 
You should have a BMI between 23kg/m2 and 35 kg/m2. 
What is involved? 
We will measure your bone density and body composition with a DXA. 
We will also measure your vitamin D status and metabolic profile.  
Study Visits and Compensation 
1 study visit, $30 compensation. Free body composition test! 
If you are interested in participating in this study, please 
contact: 
Dr. Deeptha Sukumar May Cheung 
 
Email:  projectvitd@drexel.edu Phone: (267)359-5854 
Room 317, 1601 Cherry Street, Philadelphia, PA 19102 
This research is conducted by a researcher who is a member of Drexel University 
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Appendix 2 
 
Drexel University 
Telephone Screening Form 
Name of Screener:       Date:    
The purpose of this screening interview is to see if you meet the criteria for taking part in our 
research study of the influence of ethnicity on bone mineral density (BMD), body composition 
and metabolic syndrome biomarkers in South Asian Indian men compared to Caucasian men.   
This interview will take approximately 20 minutes.   I am going to go through a list of questions.  
You may choose not to answer these questions.  You also may choose to stop participating in this 
interview at any time; if you want to stop, please tell me.   
Time 
This interview will take about 20 minutes 
Confidentiality 
Information about you that you give me during this interview will be kept as confidential as 
possible as required by law.  It is possible that the Food and Drug Administration, and other 
federal and state authorities, may inspect this record. 
Freedom to withdrawal 
You can choose if you want or do not want to take part in this research screening procedure – it is 
up to you.  If you refuse to answer the questions or stop answering them at any time, there will be 
no penalty, and you will not lose any benefits to which you otherwise would be entitled. 
Risks or Discomforts 
The risk to taking part in this interview is very small.  The screening interview is not designed to 
ask you for sensitive personal information, but it is possible that some people may feel 
uncomfortable answering these questions with a person they do not know.  If you qualify to take 
part in the study and are interested in taking part, then I will record your name and information; 
this will be kept confidential, but there is a small risk that people outside of the research team (or 
University/Hospital - state relevant unit) could learn this information.  If you are not interested in 
the study, then I will destroy the personal information you give me. 
Benefits 
The benefit to you of taking part in this interview is that you will find out whether you can take 
part in the study of determinants of bone mineral density and metabolic syndrome in South Asian 
Indian Men.  
Procedures  
This study involves a one-time visit that will last no longer than 2 hours. You will be asked to 
provide a blood sample and a urine sample during this visit. You will also be asked to fill out 
study questionnaires. We will assess your dietary intake of these nutrients along with other 
nutrients using these questionnaires. You will also receive a DXA scan.   
Alternatives 
You will not be paid for answering questions in this interview since it is only to see whether you 
qualify to take part in the study.  
Contact 
If you have any questions, concerns, or complaints about this interview, contact [Dr Deeptha 
Sukumar, Phone 215-359 5854.  If you want to talk to someone separate from the research team 
about a concern or complaint or your rights as a possible research subject, please contact Human 
Research Protection at 215-255-7857. 
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Subject Information: 
Last Name:     First Name:     
Home Phone: Work Phone:   
Cell Phone:     Email:      
Begin Telephone Screen: 
“Hi, my name is  .  I am returning your call regarding the Research study.  Thank you 
for your interest.  To begin, let me give you a little back ground about our study.  We are 
interested in determining how ethnicity influences bone mineral density, body composition, and 
metabolic syndrome related biomarkers in South Asian Indian men.”  
 “ This one-time visit will consist of blood/ urine tests and a DXA scan. You will receive a $30 
compensation for this visit. If you have a couple of minutes right now, I would like to ask you a 
few questions to determine if you are eligible to participate in the study.” 
How did you hear about this study____________________________________________? 
Note:     If you are uncertain about any eligibility question, tell the person you will check and call 
her back. 
If at any point the person is no longer eligible, please say something that sounds like the 
following:  
I am sorry but you do not fall within the inclusion criteria, I must end the interview at this time.  
Thank you for your interest in this study.” 
If Eligible Continue Here: 
1. “What is your ethnicity? ____________ 
2. “What is your age?”  years    
3.  “What is your current weight?”   pounds  
4. “Have you gained or lost weight in past few months?”      
5. “How tall are you?”  Inches   (5 ft = 60 inches) 
Please circle and write the subject’s BMI on the chart on the next page. 
Continue questionnaire if BMI is over 23kg/m2. 
BMI    
5. “Do you have any medical problems?”   
USE LIST BELOW TO ASK ABOUT THIS.  Exclude subject if he has any of the following 
conditions or is taking medications for the any of the following conditions:  
 
Condition Yes No 
Diabetes   treated with medication   
Cancer or cancer therapy within the past year   
Kidney Disease or stones within the past 5 years   
Immune Disease or on steroids to suppress immune function   
Thyroid Disorders only if unmanageable; allow if their condition is stable   
Liver Disease   
Heart Attack or Stroke in the past 6 months   
Arthritis only if on prednisone (steroid)   
6 “Are you taking any medications?”  
Yes     No    
If Yes, please list:          
7 “Have you stopped taking any medications in the past year?”  
Yes     No     If Yes, please list:       
“How long did you take them for?”         
60 Inches =   5’ 
65 Inches =   5’5” 
70 Inches =   5’10” 
72 Inches =   6’ 
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8 Do you take any osteoporosis medication (HRT, Fosomax, Actonel, Evista, Forteo, etc.)? 
9 “Have you experienced a fracture after the age of 45?” Yes     No    
If Yes, then “Was it traumatic – and where was it?”       
  (We are mostly worried about serious fractures) 
10   “Are you taking any vitamin, mineral or herbal nutritional supplements?” 
Yes     No    
If Yes, “Would you be willing to alter their regimen for the study?”:   
(Exclude if not willing.  Be sure to assure them they will be taking a Vit/Min 
   regimen recommended by us if they are eligible to participate in the study) 
11 “Do you have any food allergies (lactose intolerance, allergic to wheat, etc)?” 
Yes     No     
If Yes, please list:          
Eligibility checklist: 
    BMI within range (23 – 35 kg/m2) 
    SAI or Caucasian male 
    Age 30-50 years  
    No major medical problems and medications 
    Not on Hormone Replacement Therapy (HRT) or osteoporosis meds (past 6 months) 
Eligible Participant 
Based on the information you gave me, it looks like you are eligible for this study.  At this point, 
you have three choices.  (1) I can take down your contact information and have our staff contact 
you to set up an appointment; or (2) I can give you the number to call to set up an appointment 
yourself; or (3) if you are not interested in learning more about the study, you should say that and 
I will not keep the information collected in this interview. 
___________ OK TO CONTACT (collect contact info) 
___________ SUBJECT TO CONTACT (give contact info) 
___________ NOT INTERESTED   (destroy all information collected)  
___________ NOT INTERESTED IN THIS STUDY, BUT INTERESTED IN OTHER 
STUDIES    I would like to offer you some phone numbers and referral 
information for other programs in the area that might be better able to meet your 
needs at this time.  Would you like us to either call you back or mail that kind of 
information to you? 
___________ CALL BACK  (Phone #:                                           ) 
___________ MAIL ADDRESS                                                     ) 
Thank you for your time.  
Preferred Contact Method (check one): 
Home Phone  Work Phone     Cell Phone   Email  
  Check if contact successful 
If unsuccessful (enter date and time of call) 
  1st attempt on         
  2nd attempt on         
  3rd attempt on         
 Successful Contact on      
Notes            
Ineligible Participant: Based on the information you gave me, you are not eligible for this 
study.  Thank you for your time 
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Appendix 3 
Drexel University  
Consent to Take Part 
In a Research Study 
1. Title of research study : Determinants of Bone Mineral Density and Metabolic Syndrome in 
South Asian Indian Men 
2. Researcher: Deeptha Sukumar, PhD 
3. Why you are being invited to take part in a research study 
We invite you to take part in a research study because you meet the study criteria of being a 
South Asian Indian (SAI) or Caucasian male of ages within 20-50 years and have a Body Mass 
Index between 23 kg/m2 and 35 kg/m2. 
4. What you should know about a research study 
Someone will explain this research study to you. 
Whether or not you take part is up to you. 
You can choose not to take part. 
You can agree to take part now and change your mind later. 
If you decide to not be a part of this research no one will hold it against you. 
Feel free to ask all the questions you want before you decide. 
5. Who can you talk to about this research study? 
If you have questions, concerns, or complaints, or think the research has hurt you, talk to the 
research team at [267 359 5854 or deeptha.sukumar@drexel.edu] 
This research has been reviewed and approved by an Institutional Review Board (IRB). An IRB 
reviews research projects so that steps are taken to protect the rights and welfare of human 
subjects taking part in research.  You may talk to them at (215) 255-7857 or email 
HRPP@drexel.edu for any of the following: 
Your questions, concerns, or complaints are not being answered by the research team. 
You cannot reach the research team. 
You want to talk to someone besides the research team. 
You have questions about your rights as a research subject. 
You want to get information or provide input about this research. 
6. Why are we doing this research? 
This study is designed to investigate the influence of ethnicity on body composition and bone 
density. The SAI population has both a lower bone density and a greater risk of metabolic 
syndrome (MetS). MetS is a cluster of risk factors that increases the risk of cardiovascular disease 
and type 2 diabetes. The incidence of low bone mineral density is also higher in SAI compared to 
the Caucasian population.  This study will examine whether or not these metabolic and 
biochemical markers ( Indicators of bone building and breaking in the blood and urine, Lipids and 
other proteins) explain both low BMD and MetS in SAI men.  
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7. How long will the research last? 
This study consists of a one-time visit no longer than 2 hours.  
8. How many people will be studied? 
We expect about 60 people (30 SAIs and 30 Caucasians) will be in this research study.  
9. What happens if I say yes, I want to be in this research? 
If you are willing to participate in this study, you will be required to come to the research facility 
at 3rd floor- Room 317, 1601 Cherry street, Phildelphia, PA for one visit.  
Parcipants will expect the following during their visit: 
• This visit will last for about 2 hours 
• Blood draw- Four 5 ml tubes of blood will be collected via venipuncture 
• Urine sample collection: You will be asked to void a small amount of urine into the 
cup that is provided to you.  
• Measurement of height, weight, blood pressure, waist circumference 
• Completion of study questionnaires- This will include food diaries, medical history 
questionnaires and food frequency questionnaires. All these can be completed in less 
than 20 minutes.  
• DXA scan : This scan will enable us to measure your bone mineral density and body 
composition. It also exposes you to a small amount of radiation which is typically 
less than a day’s exposure to natural radiation.  
10. What are my responsibilities if I take part in this research? 
If you take part in this research, it is very important that you follow your physician’s or 
researcher’s instructions. 
11. What happens if I do not want to be in this research? 
You may decide not to take part in the research and it will not be held against you. 
12. What happens if I say yes, but I change my mind later? 
You agree to take part in the research now and stop at any time it will not be held against you. 
If you stop being in the research, already collected data may not be removed from the study 
database. You will be asked whether the researcher can collect data from your routine medical 
care. If you agree, this data will be handled the same as research data.  
13. Is there any way being in this study could be bad for me? 
There should be no discomforts in this study other than the blood drawing which can result in a 
temporary slight discoloration in the skin surrounding it. The DXA scan will expose you to very 
small amounts of radiation. The risks from this exposure if they exist at all are minimal.   
You and your insurance company will be charged for the health care services that you would 
ordinarily be responsible to pay. In some cases, insurance will not pay for services ordinarily 
covered because these services were performed in a research study. You should check with your 
insurance to see what services will be covered by your insurance and what you will be 
responsible to pay. 
14. Do I have to pay for anything while I am on this study? 
There is no cost to you for participating in this study.   
You will not be charged for any tests specifically required for this research study, but you or your 
insurance company will still be billed for tests or procedures that are considered “standard of 
care” and would have been part of your medical treatment even if you did not participate in this 
study. These treatment costs include but are not limited to drugs, routine laboratory tests, x-rays, 
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scans, surgeries, routine medical care, and physician charges.  Your health insurance company 
may not pay for these “standard of care” charges because you are in a research study.  If your 
insurance company  
does not pay for costs associated with this research study that are considered “standard of care” 
for your medical treatment, then you will be billed for these costs.  You are responsible for 
paying for any insurance co-pays and any deductibles due under your insurance policy, and any 
charges your insurance company does not pay. 
15. Will being in this study help me any way? 
There are no benefits to you from your taking part in this research.  
16. What happens to the information we collect? 
Efforts will be made to limit your personal information, including research study and medical 
records, to people who have a need to review this information. We cannot promise complete 
secrecy. Organizations that may inspect and copy your information include the IRB and other 
representatives of this organization.  
Data or specimens will be retained after the study for future research to examine if certain newly 
identified biomarkers such as bone turnover markers ( these are indicators of bone building and 
breakdown which can be detected in your blood or urine)  are correlated with ethinicity. Data and 
specimens will be stored in 3711 Market street, Philadelphia, PA . Access to samples beyond 
completion of the study is limited to only study personnel. 
The monitors, auditors, the IRB, the Food and Drug Administration will be granted direct access 
to your medical records for verification of the research procedures and date. By signing this 
document you are authorizing this access. 
We may publish the results of this research. This includes using data from this research for 
student research such as a master’ s thesis. However, we will keep your name and other 
identifying information confidential. 
17. Can I be removed from the research without my OK? 
The person in charge of the research study or the sponsor can remove you from the research study 
without your approval. Possible reasons for removal include, failure to follow study protocol, no 
–show for more than 3 scheduled visits or failure to meet continued study criteria due to 
illness/medications.  
18. What else do I need to know? 
This research study is being done by Drexel University. If you become ill or injured during the 
study, contact Dr Sukumar at 267 359 5854. We will get you medical care. If you need care right 
away, go to the nearest emergency room or call 9-1-1. Inform all medical emergency staff that 
you are taking part in this study. If a “research related injury” results from your participation in 
this research study, medical treatment will be provided. The cost for all your medical treatment 
will be billed to you or your insurance. “A research related injury means injury caused by 
products or procedures required by the research, which you would not have experienced if you 
had not participated in the research” 
If you agree to take part in this research study, you will be provided upto $30 compensation for 
your time and effort.  
Federal law provides additional protections of your personal information that are described here. 
Authorization to Use and Disclose Protected Health Information 
A. Individually Identifiable Health Information That Will Be Collected 
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The following personal health information about you will be collected and used during the 
research study and may be given out to others:  
Your name, address, telephone number, date of birth; 
Personal and family medical history; 
Information from laboratory tests, blood and urine tests, x-rays, physical exams and other 
tests or procedures described in this consent form. 
Information learned during telephone calls, surveys, questionnaires and office visits done as 
part of this research study; 
B. Who Will See and Use Your Health Information within Drexel University  
The researcher and other authorized individuals involved in the research study at Drexel 
University will see your health information during and may give out your health information 
during the research study. These include the researcher and the research staff, the institutional 
review board and their staff, legal counsel, research office and compliance staff, officers of the 
organization and other people who need to see the information in order to conduct the research 
study or make sure it is being done properly. Your health information may be disclosed or 
transmitted electronically. 
C. Who Else May See and Use your Health Information 
Other persons and organizations outside of Drexel University may see and use your health 
information during this research study. These include:  
Governmental entities that have the right to see or review your health information, such as 
The Office for Human Research Protections, and the Food and Drug Administration 
Doctors and staff at the hospital where this research study will take place. 
If your health information is given to someone not required by law to keep it confidential, then 
that information may no longer be protected, and may be used or given out without your 
permission. 
D. Why your health information will be used and given out 
Your information may also be used to meet the reporting requirements of governmental agencies. 
E. If you do not want to give authorization to use your health information 
You do not have to give your authorization to use or give out your health information. However, 
if you do not give authorization, you cannot participate in this research study. 
F. How to cancel your authorization 
At any time you may cancel your authorization to allow your health information to be used or 
given out by sending a written notice to Human Research Protection at 1601 Cherry Street, 3 
Parkway Bldg., Mail Stop 10-444, Philadelphia, Pennsylvania, 19102. If you leave this research 
study, no new health information about you will be gathered after you leave. However, 
information gathered before that date may be used or given out if it is needed for the research 
study or any follow-up. 
G. When your authorization ends 
Your authorization to use and give out health information will continue until you withdraw or 
cancel your authorization. 
After the research study is finished, your health information will be maintained in a research 
database. Drexel University shall not re-use or re-disclose the health information in this database 
for other purposes unless you give written authorization to do so. However, the Drexel University 
Institutional Review Board may permit other researchers to see and use your health information 
under adequate privacy safeguards. 
H. Your right to inspect your medical and research records 
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You will not be able to look at your research records while you are taking part in this research 
study. Your personal information will be made available in an emergency if doctors need this 
information to treat you. You can have access to your medical record and any research study 
information when the study is over. However, the researcher does not have to release research 
information to you if it is not part of your medical record. Use this paragraph for blinded or other 
studies where access will be denied. 
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Signature Block for Capable Adult 
Your signature documents your permission to take part in this research. 
DO NOT SIGN THIS FORM AFTER THIS DATE   
   
Signature of subject  Date 
 
 
Printed name of subject 
   
Signature of person obtaining consent  Date 
   
Printed name of person obtaining consent  Form Date 
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Appendix 4 
Please complete the following questions to the best of your ability.  If you are unclear what to 
answer, leave the space blank and we will help with the answer when you are seen at this facility.  
All answers will be kept in strict confidence and treated as information in your research record. 
 
Name: __________________________ Today’s date: ______________________ 
Address: ________________________ Date of Birth: ______________________ 
 _________________________  Race:  Caucasian__ Asian__  
        
 
If you have a preferred contact number, please check  
 
___   Home #: ______________________      ____ Cell # _________________________ 
___ Work # _________________________ E-mail: _________________________ 
Date of Last medical check-up: ____________________  
Height: _______________________ Weight: __________________________ 
Blood Pressure: ________________ Waist Circumference: _______________  
      
Yes  No 
1. Do you have a medical history of diabetes,     
hypertension or heart disease?    ___  ___ 
 
2.  Do you smoke?     ___  ___ 
 
 If yes, how much? _________________________________________________ 
3. Have you smoked in the past?    ___  ___ 
 If yes, when did you quit? ___________________________________________ 
4. Do you consume alcohol?     ___  ___ 
 If yes, how many drinks per week? ____________________________________ 
5. Have you ever been diagnosed with an eating disorder?  (binge-eating, anorexia nervosa, 
laxative abuse?  YES______  NO_______ 
 If yes please explain________________________________________________ 
 
6. Have you had any of the following conditions?: 
 Partial or complete paralysis     ___  ___ 
 Hyperthyroidism      ___  ___ 
 Juvenile diabetes      ___  ___ 
 Hypertension       ___  ___ 
 Elevated Cholesterol      ___  ___ 
Kidney Disease                               ___  ___ 
 Liver Disease       ___  ___ 
Rheumatoid Arthritis      ___  ___ 
Other Arthritis       ___  ___ 
Alcoholism       ___  ___ 
Part of stomach removed     ___  ___ 
        Y                      N 
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Inflammatory Bowel Disease     ___  ___ 
Peptic Ulcers       ___  ___ 
Malignant Disease/Cancer     ___  ___ 
  
7. Have you taken any of the following in the last year? 
 Steroids (prednisone, cortisone, etc)    ___  ___ 
 Thyroid Medication      ___  ___ 
 Anticonvulsants                  ___  ___ 
 Diuretics (water pills)      ___  ___ 
 Gluccocorticoids      ___  ___ 
 Anticonvulsants                  ___  ___ 
 Blood Thinners                               ___  ___ 
 Antacids       ___  ___ 
 Antibiotics       ___  ___ 
 Have you used steroids for more than 1 year?                                ___  ___ 
 
8. Do you have any general comments or questions about your past health?  
 __________________________________________________________________ 
9. Please list all current medications 
      _____________________________________________________________________ 
10. Please list medical problems ___________________________________________ 
11.  Have you recently lost or gained more than 10 lbs? _______  
If yes, please explain: ________________________________________________ 
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Appendix 5 
Subject ID: __________________________________________________________ 
Weight: _____________________________________________________________ 
Height: ______________________________________________________________ 
Waist circumference: (First measurement) __________________________________ 
(First measurement) ____________________________________________________ 
(First measurement) ____________________________________________________ 
Average of the three readings: ____________________________________________ 
Researcher Initial:  _____________________________________________________ 
Date: _______________________________________________________________ 
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Appendix 6 
MAGNESIUM FOOD FREQUENCY QUESTIONNAIRE 
This questionnaire determines your usual eating habits and foods high in magnesium 
Record how often you eat each food (daily, weekly or monthly) and write the number in the corresponding 
column. 
  How Often Do You Eat or Drink  
This Food or Beverage? (Fq) 
Food Source Containing 
Magnesium 
 Magnesium 
Content  
# of 
Times / 
Day 
# of 
Times / 
Week 
# of 
Times /  
Month 
 
TOTAL 
Lentils, raw 1 cup 90     
Collards, cooked, boiled, 
drained, without salt 
1 cup, 
chopped 
40     
Kale, raw 1 cup 8     
Spinach, raw  1 cup 24     
Spinach, frozen, chopped 
or leaf, cooked, boiled, 
drained, without salt 
½ cup 78     
Nuts, cashew nuts, dry 
roasted, with salt added 
½ cup 178     
Pecans ½ cup, 
halves 
60     
Seeds, pumpkin and squash 
seeds, whole, roasted, with 
salt added 
1  cup 168     
Seeds, sunflower seed 
kernels, toasted, with salt 
added 
1 cup 173     
Beans, black, mature seeds, 
canned, low sodium 
1 cup 84     
Chickpeas (garbanzo 
beans, bengal gram), 
mature seeds, canned, 
solids and liquids 
1 cup 65     
Salmon, wild, cooked, 
moist heat 
3 oz. 30     
Mackerel, Atlantic, 
cooked, dry heat 
3 oz. 82     
Fish, tuna, light, canned in 
water, drained solids 
3 oz. 20     
Chicken, broiler or fryers, 
breast, skinless, boneless, 
meat only, cooked, grilled 
3 oz. 29     
Peanut butter, smooth 
style, with salt 
2 tbsp 54     
Peanut butter, chunk style, 
with salt 
2 tbsp 51     
Banana, raw 1 small  
(6" to 6-
7/8" long) 
27     
119 
 
 
 
 
 
Strawberries, raw 1 cup, 
whole 
19     
Blackberries, raw 1 cup 29     
Raisins, seedless 1 small box 
(1.5 oz) 
14     
Quinoa, cooked 1 cup 118     
Bread, whole-wheat, 
commercially prepared 
1 slice 
(32g) 
24     
Bread, white, 
commercially prepared 
(includes soft bread 
crumbs) 
1 slice 
(25g) 
6     
Rice, brown, long-grain, 
cooked 
1 cup 84     
Cereals, oats, regular and 
quick, not fortified, dry 
1 cup 112     
Cereals, QUAKER, 
QUAKER MultiGrain 
Oatmeal, dry 
1 cup 92     
Yogurt, fruit variety, 
nonfat 
1 container 
(6 oz) 
26     
Milk, whole, 3.25% 
milkfat, with added 
vitamin D 
8 oz. 24     
Coffee, brewed from 
grounds, prepared with tap 
water 
8 oz. 7     
Orange juice drink 8 oz. 7     
Candies, SPECIAL DARK 
Chocolate Bar 
1 bar (73g) 23     
Avocado, raw, all 
commercial varieties 
 
1 cup, 
cubes 
44     
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Appendix 7 
CALCIUM FOOD FREQUENCY QUESTIONNAIRE 
This questionnaire determines your usual eating habits and foods high in calcium 
Record how often you eat each food (daily, weekly or monthly) and write the number in the corresponding 
column. 
  
How Often Do You Eat or Drink 
This Food or Beverage? (Fq) 
Food Source Containing Calcium  
Calcium 
Content 
mg 
# of 
Times
/ Day 
# of 
Time/ 
Week 
# of 
Times/ 
Month 
 
TOTAL 
Milk 
Milk 1 cup 240     
Milkshake 
1.25 
cup 
360     
Sheep milk 1 cup 380     
Coco milk 1 cup 54     
Soy drink (enriched) 1 cup 240     
Soy drink 1 cup 26     
Rice drink 1 cup 22     
Oat milk 1 cup 16     
Almond milk 1 cup 90     
Yoghurt 
Yoghurt, flavored 5 oz. 197     
Yoghurt with fruit pieces 5 oz. 169     
Yoghurt natural 5 oz. 207     
Cheese 
Hard cheese (e.g. Cheddar, Gruyere, 
Emmental, Parmesan) 
1 oz.  240     
Soft cheese (e.g. Camembert, Brie) 2 oz.  240     
Feta 2 oz.  270     
Mozzarella 2 oz.  242     
Fresh cheese (e.g. cottage cheese, ricotta, 
mascarpone) 
7 oz.  138     
Cream cheese 1 oz. 180     
Cream. Desserts 
Cream, double, whipped 2 Tsp 21     
Cream, full 2 Tsp 21     
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Custard made with milk, vanilla 4 oz.  111     
Ice cream, vanilla 3.5 oz.  124     
Pudding, vanilla 4 oz.  120     
Rice pudding 7 oz.  210     
Pancake 3 oz. 62     
Cheese cake 7 oz.  130     
Waffle 3 oz. 47     
Meat, Fish, and Egg. 
Egg 2 oz. 27     
Red meat 4 oz.  7     
Chicken 4 oz.  17     
Fish (e.g. Cod, Trout, Herring, Whitebait) 4 oz.  20     
Tuna (canned) 4 oz.  34     
Sardines in oil (canned) 2 oz.  240     
Smoked salmon 2 oz.  9     
Shrimp 5 oz. 45     
Beans and Lentils 
Lentils 
1/3 cup 
raw 
40     
1 cup 
cooked  
Chick peas 
1/3  cup 
raw 
99     
1 cup 
cooked 
White beans 
 
1/3 cup 
raw 
132     
1 cup 
cooked 
Red beans 
1/3  cup 
raw 
93     
1 cup 
cooked 
Starchy Foods 
Pasta (cooked) ¾ cup 26     
Rice (boiled) ¾ cup 4     
Potatoes (boiled) 1 cup 14     
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White bread  1 slice 6     
Wholemeal bread (1 slice) 1 slice 12     
Muesli (cereals) ¼ cup 21     
Naan 2 oz.  48     
Fruits 
Orange 5 oz. 60     
Apple 4 oz.  6     
Banana 5 oz. 12     
Apricot (3 pieces) 4 oz.  19     
Currant (dried gooseberry) 4 oz.  72     
Figs, dried 2 oz.  96     
Raisins (dried grapes) 1.5 oz. 31     
Vegetables 
Lettuce 2 oz. 19     
Kale, Collard greens (raw) 2 oz. 32     
Bok Choy/Pak Choi (raw) 2 oz. 20     
Broccoli (raw) 4 oz.  112     
Gombo/Okra (raw) 4 oz.  77     
Cress (raw) 4 oz.  188     
Rhubarb (raw) 4 oz.  103     
Carrots (raw) 4 oz.  36     
Tomatoes (raw) 4 oz.  11     
Nuts and Seeds 
Almonds 1 oz.  75     
Walnuts 1 oz.  28     
Hazelnuts 1 oz.  56     
Brazil nuts 1 oz.  53     
Sesame seeds 1 Tbsp 22     
Tahini paste 1 oz.  42     
Processed Foods 
Quiche (cheese, eggs) 7 oz.  212     
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Omelette with cheese 4 oz.  235     
Pasta with cheese 12 oz.  445     
Pizza 11 oz.  378     
Lasagna 11 oz.  228     
Cheeseburger 7 oz.  183     
Others 
Tofu 4 oz.  126     
Seaweeds 3.5 oz.  70     
Wakame 3.5 oz.  150     
Supplements  
Calcium  500 mg 500     
Calcium supplements – other amount       
This information is taken from the calcium calculator which was established by International 
Osteoporosis Foundation (IOF) Retrieved October 13, 2016, from 
https://www.iofbonehealth.org/calcium-calculator 
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Appendix 8 
Food Diary   (please note exercise / medications section) 
Meal Food Amount 
 (Please be as specific as 
you can, e.g. 1.5 cups, 3 
TBS, etc.)  
               Also Include 
method of preparation ( 
Baked/Fried) and Brand 
name 
Breakfast   
 
 
 
 
Lunch   
 
 
 
 
Dinner   
 
 
 
 
Snack 1  
 
 
 
 
 
 
Snack 2  
 
 
 
 
 
References:   
 
 
Medications (other than usual medication / also list new 
medications not included on original medical history 
form, e.g. Tylenol Cold & Flu, Aleve,etc. ) 
______________________________________________
_ 
Other concerns:  
Activity Level (self-assessed) 
                                        
  Low          Medium          High 
Type of Activity_________________ 
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